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 One of the main goals in the GML lab group is the development of novel, 
economical, and environmentally friendly organic methods for the synthesis of 
pharmacologically relevant molecular moieties. The most salient pieces of data to the 
GML lab group members, reading dependable organic journals, are finding organic 
moieties that are largely unexplored, finding organic moieties which various research 
groups are having difficulty synthesizing, and finding complex organic procedures to key 
organic structures that can be easily reduced, or reconstructed, into novel methods that 
are more economical and environmentally friendly. By looking at these unexplored 
molecules, as well as hard to reach organic moieties, the GML lab group employs various 
organic methods to break down the target moiety at hand in order to recreate these 
compounds using superior novel methodologies. In my time working within the GML lab 
group , I successfully introduced a novel synthesis route for the Lewis acid catalyzed 
synthesis of hexahydrobenzofuranones, a selective synthesis of pyrrolidines, pyrrolines, 
and azepines from haloaziridines, and a photoisomerization reaction of vinyl oxaziridines 
from vinyl nitrones. It is the hope of the GML lab to use these synthetic strategies, and 
the respective synthesis routes developed from them, to improve on existing synthetic 
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Novel Synthesis of Hexahydrofuran-4(2H)-Ones 
Hexahydrofuran-4(2H)-ones, one of the current GML lab group target moieties, 
are a part of a large family of organic compounds known as fused heterocycles; 
compounds containing two, mainly carbon based, organic ring structures which are 
bridged together at two carbons. Heterocyclic compounds are commonly used as 
privileged pharmacophores in the creation of new pharmaceutical agents. Fused 
heterocycles play this fundamental roll in drugs design as they are often good sources of 
scaffolding molecules in both blockbuster drugs and natural products in part due to do the 
structural rigidity, as well as other key features, that fused heterocycles can bring to an 
experimental pharmacophore. As mentioned before, the heterocyclic compound of 
current interest to the GML lab group is hexahydrofuran-4(2H)-ones specifically through 
the novel synthesis of fused, cyclic ethers via cycloaddition reactions between aldehydes 
and substituted cyclopropanes. Through this novel method, the GML lab group has been 
able to successfully access hexahydrofuran-4(2H)-ones, with a wide variety of 
functionalization, thus helping to meet the continuous demand for the development of 
more efficient and systematic methods to reach these key structures. Before going 
through previous synthetic routes to afford hexhydrofuran-4(2H)-ones, it is vastly 
important to cover key chemical features that these hexahydrofuran-4(2H)-one products 
embody for chemical context. 
The chemical structure of hexahydrofuran-4(2H)-ones, as shown in Figure 1, is 
characterized by a bicyclic moiety containing a six membered cyclic carbon ring structure 
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with one carbonyl functional group attached to the cyclohexane ring. If the six membered 
cyclic hydrocarbon ring, as previously mentioned, was the complete molecular structure, 
it would have the IUPAC name cyclohexanone. The cyclohexanone ring shares two 
adjacent carbons with a five membered cyclic organic ring made up of one oxygen atom 
and four carbon atoms, known by the systematic name tetrahydrofuran. The 
tetrahydrofuran ring, in the hexahydrobenzofuran-4(2H)-one final product, is further 
substituted by two electron withdrawing groups, both sharing a single carbon on the 
tetrahydrofuran ring. Various mono- and di-ester hydrocarbon chains have been 
implemented into each of the hexahydrobenzofuran-4(2H)-one moieties synthesized, 
through the second step of the novel synthesis of hexahydrobenzofuran-4(2H)-ones, in 
order to test which mono- or di-ester complex would afford the best yielding 
hexahydrobenzofuran-4(2H)-one products using the GML synthesis route. Each of the 
ester hydrocarbon complexes tested are attached to the carbon atom on the 
tetrahydrofuran ring by the mono- or di-ester carbon that is in between each of the 
carbonyl groups on the di-ester complex or adjacent to the single carbonyl functional 
group of the of the mono-ester hydrocarbon chain. This specific substituent addition 
creates an inverse stereochemical configuration of each half of the mono- or di-ester 
hydrocarbon complex. Adjacent to the electron withdrawing ester hydrocarbon 
substituents, labeled as “EWG” in Figure 1, is a “R1” labeled substituent which represents 
a variety of heterocyclic functional groups, derived from heterocyclic aldehydes 
substituted in “R1” position, in the novel synthesis of hexahydrobenzofuran-4(2H)-one. 
Using heterocyclic aldehyde substituents as the “R1” substituent gives the 
hexahydrobenzofuran-4(2H)-one moiety further rigidity and stability as well as granting 
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the final product complex the ability to be further synthesized into more complex fused 
heterocyclic compounds. 
 
Figure 1  




Now that some basic chemical characterization of hexhydrobenzofuran-4(2H)-
ones have been covered, it is important to have an overview of organic synthesis routes 
from the past towards hexahydrofuran-4(2H)-one-like products but also to envelop the 
scientific findings that laid the foundation for the optimized, novel synthesis route 
designed for the synthesis of hexahydrofuran-4(2H)-ones.  
1.1 Review of Hexahydrobenzofuranones  
In order to successfully add to the paradigm of knowledge on the synthesis of 
hexahydrobenzofuranone moieties, organic chemists must first study the synthesis routes 
towards hexahydrobenzofuranones which have already been exploited. These studies give 
key insights into the target moiety as well as potential challenges that one might run into 
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when attempting to synthesize hexahydrobenzofuranones. One of the first instances of the 
synthesis of hexahydrobenzofuranones comes from the Pharmaceutical Institute of the 
University of Kiel in 1954 by German chemists Karl W. Rosenmund, Horst Herzberg, 
and Hartwig Schutt. Rosenmund and his colleagues used hexahydrobenzofuranones as 
synthetic building blocks for the creation of a class of antiparasitic drugs known as 
anthelmintics. The synthesis for these hexahydrobenzofuranones is depicted below in 
Figure two, showing the eventual stepwise formation of the hexahydrobenzofuranone 
product 8. 
 
Figure 2  




The synthesis route, depicted above in Figure 2, begins with combining molecule 
3 with three equivalences of acetyl chloride for four hours under high pressure and heat. 
The work-up of this step then begins with cooling the reaction in an ice and salt bath 
while slowly adding 100 milliliters of ether to the crude reaction solution through rubber 
tubing to keep the reaction pressure stable. The crude reaction was then dried, to remove 
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organic solvent present, and then resuspended in twenty-five milliliters of acetic acid 
followed by dilution of the reaction with seventy-five milliliters of petroleum ether. 
Crystals were then formed and isolated in the reaction vessel to isolate compound 5. One 
gram of five molar percent palladium/barium sulfate catalyst, also known as the 
Rosenmund catalyst, 13.5 milligrams of hydrated iron three chloride in 100 milliliters of 
ethanol, and two grams of compound 5 were resuspended in 30 milliliters of ethanol until 
one mole of hydrogen had dissipated from the reaction. The Rosenmund catalyst was 
removed via centrifugation and the solution was rotatory evaporated to yield the semi-
pure, white crystal of hexahydrobenzofuranone 8. (5) The purification process was 
completed via an ether-carbonate precipitation to successfully yield the pure crystalized 
compound 8.  Rosenmund and his colleagues successfully employed 
hexahydrobenzofuranones to synthesize enol-lactone complexes of hydrogenated cyclic 
1,3-diketones containing useful anthelmintic properties. This first publication, illustrated 
above, shows that from the very genesis of the synthesis of hexahydrobenzofuranones, 
chemists intended to exploit this powerful moiety to create complex structures with 
pharmacological properties to be used in the synthesis of new pharmaceutical agents. 
Daniewski and Kowalcyk-Przewloka have shown that hexahydrobenzofuranones 
can be used precursors in the total synthesis of cyclic steroids. Figure 3 shows a step in 
the synthesis route towards cyclic steroids with molecule 1 being converted into molecule 
2 containing the hexahydrobenzofuranone moiety under relatively benign conditions. 
This process was completed by adding the inorganic catalyst tin (IV) chloride in 
methylene chloride to the starting material at room temperature. Tin (IV) chloride is 
commonly employed by organic chemists as a Lewis acid catalyst in Friedel-craft 
6 
 
reactions for alkylation and cyclization transformations as well as used with fuming nitric 
acid for selective nitration of aromatic organic structures. (7) The reaction was left 
overnight to stir which was then followed by the addition of 20 mL of water, the 
extraction of methylene chloride, drying of the reaction using sodium sulfate, and 
purification completed via flash chromatography. This reaction led to over eighty percent 
conversion of the pure diastereo-isomer of molecule 2 in figure 3 according to analyzed 
NMR spectrum data. (6) 
 
Figure 3 
Hexahydrobenzofuranone Precursor in Total Synthesis of Aromatic Steroids 
 
 
It is important to note that the functionalized tetrahydrofuran molecule, which is 
contained within the hexahydrobenzofuranone moiety, is a sought-after structure to 
synthesis in an economic fashion as it is found in plenty of natural products as well as 
active medicinal agents. Therefore, when exploring the different synthetic methods to 
establish hexahydrobenzofuranones, it is not unlikely to come across methodologies that 
are initially intended for the synthesis functionalized, stereo-controlled tetrahydrofurans. 
Functionalized tetrahydrofurans are commonly established by intramolecular 
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etherification reactions from acyclic fragments as well as from C-C bond formation. (10)  
A versatile C-C bond formation methodology used to create 3-acyltetrahydrofurans by 
stitching the carbonyl carbon of aldehydes and ketones in between the alkene and alcohol 
termini of an allylic diol. (11) While this process has high stereoselectivity as well as 
being a cornerstone reaction for the synthesis of numerous oxacyclic natural products, the 
reaction holds the limitation of an inability to synthesize tetrahydrofurans with two 
hydrogen substituents on the C5 carbon of the tetrahydrofuran produced. In the following 
procedure depicted in figure 4, Gasparski and her colleagues modify the synthesis of 3-
acyltetrahydrofurans previously mentioned, to solve the reaction’s shortcoming, through 
the development of formaldehyde oxonium ion intermediates which allow for 5-
unsubstituted tetrahydrofurans to be prepared. In order to form the oxonium ions, the 
homoallylic alcohol of the allylic diol precursors were protected with methoxymethyl, 
OMOM, and to prevent the formation of 1,3-dioxolane the allylic alcohol was protected 
via a tert-butyldimethylsilyl, TBS, functional group. As seen in Figure 4, the allylic diol 
precursor on the left is exposed to a solution of boron trichloride in the organic solvent 
dichloromethane, DCM, at -78 degrees Celsius for one to two hours. The mechanistic 
studies, reported by Gasparski’s group, showed a Prins cyclization-pinacol rearrangement 
pathway for the synthesis of 5-unsubstituted tetrahydrofurans. The Lewis acid catalyzed 
organic synthesis shown in this example successfully proves the synthesis of 






Figure 4  





Another interesting method employed Yu et al was to utilize hydrogenation 
reactions to create multi-substituted cyclohexanes with discrete stereogenic centers. In 
Yu’s lab group esterified 1,3-cyclohexanediones were employed to build polysubstituted 
cyclohexane skeletons. These esterified 1,3-cyclohexanediones underwent 
desymmetrization/transesterification cascade reactions when exposed to a chiral 
ruthenium catalyst and a formic acid/triethylamine solution in ethyl acetate at 25 degrees 
Celsius for 24 hours in order to afford hexahydrobenzofuranones. (16) Yu et al’s method 
allows for the continuous access to chiral multi-substituted cyclohexane skeletons to be 
then transformed, in future organic projects, for natural product synthesis. 
As seen in some of strategies mentioned before, the creation of 
hexahydrobenzofuranones is commonly accomplished under the addition of specific 
Lewis acids, but the mechanistic strategies to achieve these key moieties differs in each 
research group. Stereo-selective synthesis of hexahydrobenzofuranones was pursued by 
Herrinton et al through ring enlarging furan annulations. (12) In this synthesis, a variety 
of substituted cis-fused hexahydrobenzofuranones, octahydrobenzofuranones, and 
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cycloheptanetetrahydrofuranones were established through acid-promoted rearrangement 
of acetals derived from 1-alkenyl-2-hydroxycyclopentanols as well as 1-alkenyl-2-
hydrocyclopentanols. Several Lewis acids were successfully utilized by Herrinton and his 
colleagues towards this synthesis route including boron trifluoro etherate, tin 
tetrachloride, ethylaluminum dichloride, and magnesium bromide. It was later discovered 
that the Lewis acid dimethylaluminum chloride was ineffective for these procedures. 
While this strategy for creating fused bicyclic moieties was tested with organic rings of 
only three sizes, Herrinton and his group believe that this can be applied to even larger 
rings as well as applying this route to the synthesis of pharmaceutically relevant complex 
cyclic ethers. (12) 
Radical reagents are also used to catalyze the synthesis of hexahydrobenzofuranones, 
such as tri-n-butyltin hydride, which can be employed to induce reductive cleavage, 
radical dehalogenation, and radical cyclization reaction. (15) This is exemplified by 
Macdonald and Burnell as they developed a synthetic pathway towards the natural 
product Pestaloficiol A, using the hexahydrobenzofuranone moiety as a molecular 
foundation, which was found to have anti-HIV activity. (13) In this section, the synthesis 
towards the hexahydrobenzofuranone moiety will only be described as the rest of the 
synthesis pathway towards Pestaloficiol A will be explored in the 
hexahydrobenzofuranone pharmaceutical application section. As shown in Figure 5, 
Macdonald and Burnell prepared the hexahydrobenzofuranone precursor for Pestaloficiol 
A by first reaction propargyl alcohol with cyclohexanone in the presence of NBS and 
sulfuric acid to give the bromo ether starting material in Figure 5. This was then followed 
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by inducing radical cyclization of the bromo ether starting material with tri-n-butyltin 
hydride to give the hexahydrobenzofuranone complex in 88% -92% yield.  (14) 
 
Figure 5  




Recent organic studies completed by Xiao’s group found that phosphine catalysts 
can be applied towards dearomative [4+2] cycloadditions in order to create 
hexahydrobenzofuranone containing moieties. It was found from Xiao’s group, after 
exploring various phosphine catalysts used by other organic research groups, that 
phosphine catalysts which were substituted by fused bicyclic as well as 3,5-
dimethylphenyl substituents showed greater success in producing 
hexahydrobenzofuranone moieties. In this synthesis strategy, 1-(benzofuran-3-yl) prop-2-
en-1-one was reacted with a highly electrophilic 3-olefinic 7-azaoxindole catalyzed by 
the cyclic phosphine catalyst at 5 degrees Celsius for twelve hours synthesized 
hexahydrobenzofuranones containing moieties in 88% stereoselective yields. (17) This 
methodology could prove to be quite economically useful in industry as it creates 
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principle hexahydrobenzofuranone moieties in a one pot reaction under relatively mild 
conditions. 
Photo-organocatalytic reactions have been a staple strategy employed by organic 
chemists as they provide simple organic procedures under lenient conditions to create 
otherwise hard to reach organic scaffolds. The next two synthetic examples will cover 
two groups that have employed photocatalytic reactions to afford 
hexahydrobenzofuranone moieties. The first synthetic schematic, applied by Perego’s 
group, explored single-electron transfer (SET) activation of allenes through a light-driven 
enantioselective organocatalytic process. (18) To begin this process, chiral iminium ions 
were photocatalytically transformed into their excited state to activate allenes through the 
SET oxidation. The activated allene cation radicals then participated in stereo-controlled 
cascade reactions to deliver chiral bicyclic hexahydrobenzofuranone scaffold with good 
enantioselectivity and diasteroeselectivity. Lewis acids were later employed for Perego’s 
synthetic strategy in order to assist in the formation of the activated chiral iminium ion 
providing higher yields and full diastereoselective control of the reaction. (19) 
While photochemical reactions have proven to be useful tools in the synthesis of 
complex organic scaffolds such as hexahydrobenzofuranones, the efficiency of these 
photo-induced reactions are restrained, especially when using batch reactors, by the 
amount of light that is able to penetrate through the reaction media. (20) To combat this 
drawback to photochemical, El Achi’s group employs the use of a continuous flow 
system reactor as microfluidic systems have small optical path lengths to ensure more 
efficient sample irradiation as well as being a simple and cost-effective reaction system. 
(21) El Achi’s group uses the continuous flow system to provide kinetic and optimization 
12 
 
studies on their intramolecular [2+2] photocycloaddition of 3-alkenyloxy-2-
cycloalkenones derivates under UV-A irradiation. El Achi’s group successfully 
demonstrated a photo-catalytically sensitized intramolecular [2+2] cycloaddition using 
the photosensitizer DMBP in a commercial photomicroreactor irradiated by High Power 
UV-A LEDs forming hexahydrobenzofuranone containing structures in a 2-hour reaction 
time. (22) 
Photo-organocatalyzed cycloadditions reactions are known to undergo free-
radical mechanisms but inducing radical cyclization reactions through other catalytic 
systems can also be a versatile method applied to synthesize polycyclic fused 
heterocycles which contain similar organic moieties to the hexahydrobenzofuranone 
scaffolds. The use of radicals allows organic chemists to include high functionality 
tolerance, within mild reaction conditions, which leads to high levels of regio- and 
stereoselectivity within the achieved organic products. (23) Namely, reductive radical 
cyclization has been a prominent organic strategy to afford 6-5 fused bicyclic structures 
which closely resemble hexahydrobenzofuranones.  
In these reductive methodologies, the initial radical is generated via a one-electron 
transfer agent towards the precursor of the reaction. (24) This method is quite suitable for 
cyclization reactions as the nucleophilic radicals enabled by this method are not easily 
reduced. A good example of this reductive radical reaction outlined previously is 
Molander and Harring’s work in which samarium (II) iodide in the organic solvent 
tetrahydrofuran is mixed with hexamethylphosphoramide at 25 degrees Celsius to 
transform 1-(allyloxy)-2-iodobenzene into a dihydrobenzofuran complex. In this 
reductive method, aryl iodides and/or bromides are used as precursors which generate an 
13 
 
aryl radical through single-electron transfer followed by the loss of iodide. The cyclic 
radical is then reduced to an organometallic intermediate, often involving the metal 
complex mentioned previously, samarium (II) iodide, for its solubility in organic 
solvents, high reducing power, and excellent chemo-selectivity. (25) This organometallic 
intermediate is then able to react with electrophilic molecules completing this radical 
cyclization reaction and affording hexahydrobenzofuranone structures.   
Another radical organic strategy involving the use of samarium (II) iodide is in 
sequential radical cyclization, specifically where fragmentation of the precursor precedes 
the cyclization. Sequential reactions are useful in radical reactions as most radical 
reactions such as fragmentation, cyclization, or addition product a new radical that can 
serve as a precursor for the second radical reaction to occur. (26) As seen by the reaction 
schematic below in figure 6, the initial radical is formed by fragmentation of the 
cyclopropyl ketone in order to then produce chiral radicals through a secondary radical 
reaction. This reaction is possible as cyclopropanation methods can produce precursors 
for radical reactions which are optically pure. (27) This same method can also be 
employed for an oxygen centered radical if epoxide is used in place of the cyclopropane 
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While metal hydride-based reagents are commonplace in initiating radical 
cyclization reactions, chain transfer agents can also be utilized to conduct fragmentation 
reactions of cyclic radicals which contain hexahydrobenzofuranone-like moieties.(23) 
One example of this, completed by Smith et al, generated a sulfone radical through 
reversible addition to a double bond to initiate radical isomerization reaction.  During this 
reaction, an allylic sulfone was cyclized with benzoyl peroxide and carbon tetrachloride 
in reflux. The main advantage for this synthetic pathway lies in the fact that there is no 
competition with side reactions occurring in the direct reduction of the radical acceptor 
due to the lack of the metal hydride in the reaction. With this lack of reaction 
competition, slow cyclization reactions can be conducted with less reactive precursors as 
well as the ability to maintain double bonds within the transformed structure. (28) As 
seen in the last few synthetic examples, radical cyclization reactions allow for diverse 
strategies to afford hexahydrobenzofuranones, or structures that are easily transformed 
into them. As seen through this selection of works to produce hexahydrobenzofuranones, 
there are many organic strategies that have employed a variety of catalytic systems to 
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create hexahydrobenzofuranones, but there are still many unexplored organic strategies 
which can be exploited for innovative and economical reactions that create and use these 
crucial organic structures. 
1.2 Pharmaceutical Relevance  
 One of the major focuses of the Moura-letts lab group is the development of novel 
organic methods to synthesis small organic molecules that are likely to have biological 
activity. The creation of new biologically active organic compounds act as the foundation 
for the entire process of creating new pharmaceuticals. When a scope of organic 
compounds is first synthesized, which have a high likelihood of being biologically active, 
it can then be run through a series of biochemical experiments such as biological-activity 
matrices, high-throughput phenotypic screens, various protein-binding assays to confirm 
their activity. (3) Once the organic molecules within the new organic scope are vetted 
through screening for biologically active, they have the chance of being manipulated as 
scaffolding molecules, building blocks for complex pharmacophores, or even used as a 
complete pharmacophores, in the pharmaceutical industry and academia, for the 
development of pharmaceutical agents of the future. Pharmacophores can be 
characterized as an ensemble of organic moieties and/or functional groups which contain 
crucial steric and electronic features. These key features are required to ensure optimal 
organic supramolecular interactions with a specific biological target as well as 
trigger/block the target’s effects. (2) A large family of organic compounds known as 
fused heterocycles, two adjacent ring structures that share two carbons, are commonly 
used as privileged pharmacophores. (1) The following section will discuss a range of 
synthetic methods for the application of hexahydrobenzofuranones, used by organic 
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chemists in academia and in industry, to develop new pharmaceutical agents as well as 
the medicinal properties that these pharmaceutical agents hold. 
 
Figure 7 




As mentioned previously, hexahydrobenzofuranones are crucial target moieties as 
they can lead to the novel development of featured organic structures as well as serve as 
the backbone for new biologically active molecular scaffolds. Daniewski’s work on the 
synthesis route towards hexahydrobenzofuranones, within the total synthesis of aromatic 
steroids, is a great example of just one of the synthetic applications that 
hexahydrobenzofuranones can bring. In Figure 7, shown above, it can be seen how once 
synthesized, the hexahydrobenzofuranone containing structure on the left can undergoes 
a simple hydrogenation reaction followed by acetic acid and perchloric acid catalyzed 
cyclization to afford the 6,6,6,5 steroidal backbone. (6) At this point the steroidal 
backbone can be easily converted in any steroid for use as pharmacological agents or for 
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further manipulation to create even more complex, biologically active polycyclic 
structures. 
Coming up with novel synthetic strategies for the total synthesis of natural 
products is a crucial endeavor which is undertaken by many organic chemists. The 
following examples include natural product synthesis where hexahydrobenzofuranones 
are used as synthetic precursors to afford natural products. One of the most profound 
features of hexahydrobenzofuranones are their ability to be transformed into featured 
natural products. As mentioned in Figure 5, Macdonald and Burnell aimed to use the 
hexahydrobenzofuranone skeleton in order to complete the natural product synthesis of 
Pestaloficiol A. Pestaloficiol A is a colorless oil isolated from the plant endophyte 
Pestalotiopsis fici which has shown to be a rich source of bioactive secondary 
metabolites with diverse structural features. (29) One of the most prominent bioactive 
metabolites that have been isolated from this plant source thus far is chloropupukeananin, 
the first chlorinated pupukeanane derivate which possesses anti-HIV-1 properties from its 
highly functionalized tricyclo-decane skeleton. (30) As seen in Figure 8 above, the 
hexahydrobenzofuranone skeleton, formed by through a radical cyclization reaction, was 
acylated by a R, β-unsaturated acid chloride to afford the molecule on the top right of 
Figure 8. This molecule was then headed in 1:1 THF/water solution with 0.1 
equivalences of TsOH to induce cyclization to afford polycyclic structure, in 80 percent 
yields, which can be then converted through further organic transformations into 





Pestaloficiol A Natural Product Synthesis 
 
 
Rogers and Keay have also utilized and studied the effects of 
hexahydrobenzofuranones as a key intermediate for the synthesis of the natural product 
1,4-epoxycadinane. 1,4-epoxycadinane is an important organic target as it is isolated 
from the brown algae Dilophus fasciola and known to have a large variety of biological 
activity, such as antimicrobial and adhesive properties, which are applicable in 
pharmacology. (31) The hexahydrobenzofuranone moiety was synthesized via an 
intramolecular Diels-Alder reaction of the Furan diene (IMDAF) connecting the furan 
diene to the dienophile which was separated by a four-carbon chain. The furan diene was 
dissolved in dichloromethane containing florisil and stirred under argon for an allotted 
amount of time. (32) Once the hexahydrobenzofuranone containing structure was 
isolated, depicted in Figure 9, it was applied to the synthesis of 1,4-epoxycadinane.  
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Another application of the hexahydrobenzofuranone skeleton was deployed by 
Endoma-Arias and Dela Paz in developing derivatives of 10-keto opiates as well as 10-
hydroxy-morphinans for use as selective, opioid receptor κ analgesics. (33) Of the three 
types of opioid receptors, µ, δ, and κ, in the body the κ-opioid receptor has piqued the 
interest of researchers recently as, when activated, the κ receptor produces analgesia with 
minimal physical dependence. (34) This means that drugs that come about as highly 
selective κ-opioid receptor agonists would prove to be useful analgesics as well as free 
from abusive potential. (35) In order to synthesize key structures such as 10-keto opiates, 
10-hydroxy-morphinans, and related morphine alkaloids, a hexahydrobenzofuranone 




Natural Product Synthesis of 1,4-Epoxycadinane 
 
 
In another application of hexahydrobenzofuranones for useful synthetic 
transformations, Yu’s group have synthesized a hexahydrobenzofuranone-containing, 
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fused 6,3,5-tricyclic intermediate in order to afford the antibiotic mycorrhizin A. 
Mycorrhizin A was first isolated and characterized by Wickberg and Trofast in 1977 
from a sterile mycelium of an endomycorrhizinal fungus.  (36) This target compound 
possesses a variety of biological activities which could be employed in antifungal and 
antibiotic pharmaceutical agents. (37)  Previous efforts towards the synthesis of the basic 
angularly fused 6,3,5-tricyclic skeleton has been limited to date as only two elegant 
strategies have been reported for such tricyclic ring systems. The first  synthetic approach 
was revealed by Smith’s group, in which an intramolecular SN2 reaction was utilized for 
construction of the cyclopropane ring of the tricyclic system, and the second was 
introduced Brown and co-workers reporting the synthesis of these structures through 
cycloaddition of diazomethane and an olefin followed by extrusion, through ultraviolet 
irradiation, of the nitrogen from the reaction, leading to the formation of the 
cyclopropane ring of the tricyclic system.  (38) (39) Yu and colleagues provided a new 
method to afford this 6,3,5-tricyclic structure through intramolecular cyclization of a π-
nucleophile with an epoxide-containing adduct. Yu and his co-worker’s reaction proceed 
via an initial attack of the double bond on the epoxide ring leading to a 
cyclopropylcarbinyl cation intermediate. The intermediate formed, however, is to be 
considered as a nonclassical or delocalized cation that is unstable without the correct 
substituents at the appropriate positions. If these substituents were not in place, ring-
opening and rearrangement procedures would be induced on the intermediate. Among the 
Lewis acids employed by Yu to catalyze this reaction, BF3OET2 and CF3SO3H, in 
acetonitrile at room temperature for 3-5 minutes, were found to promote the 3-exo 
cyclization of the allylic epoxide to give the desired fused 6,3,5-tricyclic product in the 
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best yields. (40) With the formation of this tricyclic, hexahydrobenzofuranone-containing 
intermediate, the subsequent transformations are easily performed to afford the 
biologically active Mycorrhizin A molecule. 
One final example of the application of the hexahydrobenzofuranone moiety can 
be seen by the work of Ghosh and co-workers in their synthesis of a series of HIV-1 
protease inhibitors which incorporate, hexahydrobenzofuranone-containing, fused 
tricyclic P2 ligands.  While HIV-1 protease inhibitors have always been a staple among 
antiretroviral drug therapies, the rapid advancement of drug-resistance had interrupted the 
clinical benefits that HIV-1 protease inhibitors can bring. (41) To combat this issue, 
Ghosh and co-workers focused their inhibitory design on maximizing the active sit 
interactions with protease by promoting substantial hydrogen-bonding interactions with 
the backbone atoms throughout the active site. (42) Through the development of Ghosh’s 
HIV-1 protease inhibitors from structure-based design targeting the protein backbone, it 
was found that the syn-anti-syn-fused tricyclic P2 ligand moiety within the HIV-1 
protease inhibitor was responsible for enhanced broad-range potency as well as 
effectiveness against a range of multidrug-resistant HIV-1 variants. (43) (44) The 
synthesis of these tricyclic P2 ligand derivatives and subsequent HIV-1 protease 
inhibitor, depicted in Figure 10, shows the hexahydrobenzofuranone-containing enone 
exposed to hydrogenation over 10% Pd-C in MeOH at 65 psi hydrogen pressure to afford 
the resulting ketone. The reduction of the ketone with NaBH4 in MeOH followed 
resulting in the endo alcohol formation shown in the bottom right of Figure 10. The 
ligand alcohol was then reacted with para-nitrophenyl chloroformate and pyridine in 
dichloromethane to provide mixed carbonates. The mixed carbonates were then 
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transformed into the subsequent HIV-1 protease inhibitors by exposing them to the 
optically active amine, labeled as molecule 6 in Figure 10, in the presence of triethyl 
amine in acetonitrile. (45) The synthesized protease inhibitor derivatives were then 
evaluated in antiviral assays to access their antiviral and enzymatic potencies. The 
protease inhibitor at the bottom left of Figure 10 showed impressive antiviral and 
enzymatic properties having an IC50 of 1.9nM. The IC50 values for each protease inhibitor 
were determined via an MTT assay which assesses cell metabolic activity through 
exposing tetrazolium dye MTT, usually yellow in color, to be reduced to its insoluble 
formazan, qualitatively indicated by a yellow to purple color change. The protease 
inhibitors developed by Ghosh and co-workers proved to maintain activity against a panel 
of multidrug resistant HIV-1 variants along with giving insights into the ligand-binding 
site interactions through X-ray crystal structures. As shown through the examples in this 
section, hexahydrobenzofuranones are crucial organic structures as they are available for 
a wide variety of organic applications and transformations, affording truly powerful 
pharmaceutical agents. For this reason, it is imperative to continue to develop mild, easy-
to-reproduce, and economical organic conditions to afford these key structures for the 









Figure 10  




1.3 Method Discovery 
As there are many instances of the hexahydrobenzofuranone moiety featured within 
key natural products and biologically active molecules, utilized in the development of 
new pharmacophores, there is a continuous need for new synthetic strategies to be 
developed to gain access these organic structures. To afford these crucial structures 
within mild reaction procedures, the GML lab group proposed a 
hexahydrobenzofuranone reaction hypothesis depicted in Table 1. The GML 
hexahydrobenzofuranone reaction hypothesis begins with the bromination of 
commercially bought cyclohex-2-ene-1-one in the presence of triethylamine in the 
organic solvent dichloromethane. A subsequent Michael-initiated cyclopropanation 
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reaction was conducted on the constructed 2-bromocyclohex-2-ene-1-one to afford the 
oxobicyclo [4.1.0] heptane-7,7-dicarboxylate moiety. (54) Finally, a Lewis acid catalyzed 
[3+2] cycloaddition reaction between benzaldehyde derivatives and the previously 
established oxobicyclo [4.1.0] heptane-7,7-dicarboxylates to generate the 
hexahydrobenzofuranone moiety. (55) 
 
Table 1 







1.4 Results and Discussion 
As this combination of reaction procedures and organic complexes have never been 
explored previously, optimization studies on this synthetic route are necessary in order to 
ensure that the oxobicyclo [4.1.0] heptane-7,7-dicarboxylate products, and subsequent 
synthesis of hexahydrobenzofuranones products, are constructed in the highest yielding, 
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stereo- and regioselective manners. As seen in Table 2, optimization studies for the 
synthesis of oxobicyclo [4.1.0] heptane-7,7-dicarboxylates began with changing the 
organic solvent the reaction was run in to see which would afford the highest yields. As 
dimethyl sulfoxide, DMSO, was proven to be the best choice for this reaction the reaction 
concentration was then tested to optimize the appropriate amount of reaction collisions 
within the organic solvent media. DMSO at a reaction molarity of 0.1M provided the best 
conversion rate in this case which was confirmed by chromatographic methods such as 
TLC as well as by proton and carbon NMR spectra analysis. Finally, it was important to 
find the highest yielding malonic acid derivative, which acted as the Michael donor in the 
cyclopropanation reaction, in order to accurately access the subsequent benzaldehyde 
scope within the [3+2] cycloaddition to afford the hexahydrobenzofuranone moiety. The 
optimized reaction conditions for the cyclopropanation step of the synthesis of 
hexahydrobenzofuranones used ethyl 3-oxoheptanoate as the malonic acid Michael 
donor, 0.1M DMSO organic solvent to promote higher yields, potassium carbonate to 
promote trans-stereochemistry in the cyclopropanation product, inert reaction conditions 
under elemental nitrogen gas, heating the reaction to eighty degrees Celsius on a hotplate, 
and stirred for twenty-four hours which produced oxobicyclo [4.1.0] heptane-7,7- 
dicarboxylates in 85% isolated yields. The reaction work-up, as well as the purification. 
of these oxobicyclo [4.1.0] heptane-7,7-dicarboxylates was especially troublesome as 
DMSO is an extremely polar solvent which made it very difficult to dry the reaction in 
preparation for flash chromatography. A secondary issue encountered in this step of the 
reaction was the crude TLC of each oxobicyclo [4.1.0] heptane-7,7-dicarboxylate had 
four to five spots on each TLC plate of very similar Rf values, making the following flash 
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chromatographic procedures exceedingly difficult. The reaction scope for the synthesis of 








 Following the optimization of the synthesis of oxobicyclo [4.1.0] heptane-7,7-
dicarboxylates and the production of the oxobicyclo [4.1.0] heptane-7,7-dicarboxylate 
reaction scope, the optimization of the final step of the synthesis of 
hexahydrobenzofuranones was began by using the ethyl 2-oxo-7-pentanoyl bicyclo 
[4.1.0] heptane-7-carboxylate as the oxobicyclo [4.1.0] heptane-7,7-dicarboxylates 
precursor for the Lewis acid catalyzed [3+2] cycloaddition reaction. For this reaction 
step, dichloromethane and dichloroethane were used as organic solvents with a variety of 
27 
 
reaction concentrations to access the best yielding reaction. It was found that 
dichloroethane with a solvent concentration of 0.1M, using the 4-pyridine 
carboxaldehyde afforded the best yield to produce the hexahydrobenzofuranone moiety. 
The mechanism for the final step of the synthesis of hexahydrobenzofuranones is thought  
to occur via a Lewis acid induced dipole along the carbonyl of the benzaldehyde 
derivative, causing the benzaldehyde to act as nucleophile, inducing an inversion of 
stereochemistry at the C2 carbon of the cyclopropane ring of the ethyl 2-oxo-7-pentanoyl 
bicyclo [4.1.0] heptane-7-carboxylate structure. This inversion of stereochemistry of the 
C2 carbon opens the cyclopropane ring in the ethyl 2-oxo-7-pentanoyl bicyclo [4.1.0] 
heptane-7-carboxylate structure allowing for the [3+2] cycloaddition to then occur. 
Challenges were met with the purification of the hexahydrobenzofuranones as 
diastereomeric forms of hexahydrobenzofuranones were produced from the reaction 
having Rf values, by crude TLC, that were almost identical. Table 6 shows the afforded 


















 While the novel synthesis of hexahydrobenzofuranones has been afforded by the 
GML lab group, there are still other complimentary synthetic routes to be explored, 
through future organic synthetic endeavors, to afford fused bicyclic organic constructs 
from the oxobicyclo [4.1.0] heptane-7,7-dicarboxylate derivatives generated in the GML 
novel synthetic strategy. As seen in Table 6, nitrones, diaziridines, cyclic alkynes, imines, 
oxaziridines, isocyanates, and nitriles can be used in place of the benzaldehyde 
derivatives to form these bridged heterocycles through novel synthetic strategies. With 
this collection of fused bicyclic structures, a multitude of transformations can be tested in 
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order to form crucial pharmacophores, which are likely to have biologically active, 














































































Using the optimized novel synthetic conditions developed by the GML lab group, a 
diastereoselective, efficient, and convergent approach towards the selective synthesis of 
fused-cyclic hexahydrobenzofuranones from oxobicyclo [4.1.0] heptane-7,7-
dicarboxylates and aldehydes have been developed under mild Lewis acid reaction 
conditions. The novel synthesis of hexahydrobenzofuranones has shown to occur under a 
wide variety of substitution patterns along with producing complex organic products in 
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high yields. This reaction provides competent access to highly functionalized 
heterocyclic structures from simple-to-synthesize scaffolds allowing for future synthetic 
approaches towards more complex heterocyclic pharmacophores. A large variety of 
derivative synthetic routes have also begun development, using this novel synthesis for 
foundational knowledge, to apply these synthetic strategies towards the creation of a wide 
variety of fused-cyclic complexes. 
1.6 Experimental  
Organic reagents were obtained from Aldrich Chemical, Acros Organics, and Alfa 
Aesar. Organic reactions were performed with 20 milliliter glass vials that allowed for 
magnetic stirring. TLC analysis was performed via a 0.25mm E. Merck silica gel 60 F254 
plates and visualized under 254 nm UV light as well as staining with potassium 
permanganate solution (KMnO4). Products were purified via manual silica-gel flash 
chromatography and collected based on NMR analysis and Rf values of UV spots by 
TLC. NMR spectrum were recorded via Varian Mercury II 400 MHz Spectrometer at 24 
degrees Celsius in CDCl. Chemical shifts are expressed in ppm relative to solvent 
signals: CDCl, (1 H, 7.23 ppm; 13C, 77.0ppm; coupling constants expressed in Hz) 
1.6.1 General Method for Synthesis of Oxobicyclo [4.1.0] Heptane-7,7-Dicarboxylates 
The procedures for the first step in the synthesis of the functionalized 
hexahydrobenzofuran-4(2H)-one products is bromination of commercially bought 
cyclohexa-2-en-1-one into 2-bromocyclohex-2-en-1-one. To set up this first step 
bromination reaction, the solvent dichloromethane (DCM) was added into a round bottom 
to stir in an ice bath; enough DCM was added to achieve a reaction concentration of 
0.1M. Once the solvent was cooled to zero degrees Celsius, 1.1 equivalence of elemental 
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bromine (Br2) was added dropwise followed by dropwise addition of 1.1 equivalence 
triethylamine. The reaction was left to stir overnight for workup the following day. The 
reaction was worked up via liquid/liquid extraction with a polar solvent, such as ethyl 
acetate, and the organic layer was then collected. The organic layer was washed with 
saturated sodium bicarbonate solution, water, and finally brine. The organic layer was 
then dried with sodium sulfate followed by gravity filtration, drying of solvent via 
rotatory evaporation, and finally analysis/confirmation of product of first step product via 
proton/carbon NMR, infrared spectroscopy (IR), and mass spectrometry (MS). Once 2-
bromocyclohex-2-en-1-one was confirmed via analysis, the set up for the second step of 
the synthesis of functionalized hexahydrobenzofuran-4(2H)-one was begun. 
The procedures for the second step of the synthesis of functionalized 
hexahydrobenzofuran-4(2H)-ones aimed to transform pure, crystalized 2-bromocyclohex-
2-en-1-one into 1,1'-(2-oxobicyclo[4.1.0]heptane-7,7-diyl)bis(ethan-1-one), which is 
depicted on the top right of the substrate synthesis schematic in figure 2. Pure, crystalized 
2-bromocyclohex-2en-1-one was weighed to the reaction scale and added into the organic 
solvent dimethyl sulfoxide, (DMSO), to create a reaction concentration of 0.1M. Two 
equivalences of potassium carbonate were then added into the reaction vial and a rubber 
stopper was secured to the top of the 20 mL reaction vial via parafilm.  The reaction vial 
was then made inert with elemental nitrogen gas (N2) and the nitrogen gas was 
continuous run through the reaction vial while the pentane-2,4-dione was syringed into 
the stirring reaction. The reaction stirred overnight at 80º Celsius for workup the 
following day.  
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The reaction was taken off the heat and allowed to cool to room temperature 
followed by gravity filtration. Liquid-liquid extraction was performed on the resulting 
product solution with 3:1 ratio of ethyl acetate (EtoAc) to di methyl sulfoxide (DMSO) 
reaction solution and the ethyl acetate layer was collected. The ethyl acetate organic layer 
was washed with water twice and dried with sodium sulfate followed by gravity filtration. 
The crude product organic solution was rotatory evaporated down and the resulting crude 
oil was characterized/confirmed by proton and carbon NMR, infrared spectroscopy (IR), 
and mass spectrometry (MS). Once the crude product was confirmed, manual, silica-
based, flash column chromatography was performed to isolate the pure second step 
product shown in the top right of figure 2. The pure second step product was 
characterized/confirmed via proton/carbon NMR, infrared spectroscopy (IR), and mass 
spectrometry (MS). Once the creation of one of the 1,1'-(2-oxobicyclo [4.1.0] heptane-
7,7-diyl) bis(ethan-1-one) products were confirmed, the third and final step of the 
synthesis of functionalized hexahydrobenzofuran-4(2H)-ones were set up. 
1.6.2 General Method for the Synthesis of Hexahydrofuranones  
 Each pure 1,1'-(2-oxobicyclo [4.1.0] heptane-7,7-diyl) bis(ethan-1-one) product, 
of the second step of the functionalized hexahydrobenzofuran-4(2H)-ones synthesis, was 
added to a stock solution of the solvent dichloroethane (DCE) under elemental nitrogen 
gas. Inert dichloroethane was poured into a clean 250 mL round bottom under argon gas, 
via an inert solvent dispenser, and a rubber stopper was placed to cap the round bottom. 
Elemental nitrogen gas was set to flow throw the round bottom and out of a syringe vent 
in the rubber stopper. The scaled number of milliliters of pure 1,1'-(2-oxobicyclo [4.1.0] 
heptane-7,7-diyl) bis(ethan-1-one) product dichloroethane stock solution was added into 
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the 250-milliliter round bottom while the elemental nitrogen gas was running through the 
round bottom. The aldehyde was then syringed into the 250-milliliter round bottom while 
the nitrogen gas was still running and finally the triflic acid was diluted to 10 mol % 
stock solution of dry dichloroethane under argon and was then carefully syringed into the 
250 mL reaction round bottom. Positive pressure was added to the round bottom by 
removing the vent syringe and then the nitrogen gas syringe a few seconds later. The 
reaction was run overnight. Once the crude product was confirmed, manual, silica-based, 
flash column chromatography was performed to isolate the pure final step product shown 
in Figure 2. The pure final step of the synthesis of hexahydrobenzofuran-4(2H)-ones was 
characterized/confirmed via proton/carbon NMR, infrared spectroscopy (IR), and mass 
spectrometry (MS). 




Ethyl 7-(4-methylbenzoyl)-2-oxobicyclo[4.1.0]heptane-7-carboxylate (2c): 
Purification via manual silica gel flash chromatography (20:1 heptanes/EtOAc to 1:1 
heptanes/EtOAc) afforded the oxobicyclo [4.1.0] heptane-7,7-dicarboxylates product 2c 
(86% yield) as an amber oil. 1H NMR: (400 MHz, Chloroform-d) δ 1.28 (3H, t, J = 7.1 
Hz), 1.66-1.95 (5H, 1.74 (dtdd, J = 13.4, 10.2, 2.9, 2.3 Hz), 1.76 (dddd, J = 13.1, 7.9, 2.9, 
2.6 Hz), 1.77 (dddd, J = 13.1, 10.2, 3.2, 2.8 Hz), 1.82 (ddd, J = 8.1, 7.9, 2.8 Hz), 1.87 
(ddddd, J = 13.4, 3.3, 3.2, 2.6, 2.2 Hz)), 2.18 (1H, d, J = 8.1 Hz), 2.32-2.58 (2H, 2.39 
(ddd, J = 14.6, 3.3, 2.3 Hz), 2.50 (ddd, J = 14.6, 10.2, 2.2 Hz)), 3.79 (3H, s), 4.09-4.20 
(2H, 4.14 (q, J = 7.1 Hz), 4.14 (q, J = 7.1 Hz)), 7.08 (2H, ddd, J = 8.3, 1.2, 0.4 Hz), 8.02 









Ethyl 7-(4-nitrobenzoyl)-2-oxobicyclo[4.1.0]heptane-7-carboxylate (2d): Purification 
via manual silica gel flash chromatography (20:1 heptanes/EtOAc to 1:1 heptanes 
/EtOAc) afforded the oxobicyclo [4.1.0] heptane-7,7-dicarboxylates product 2d (60% 
yield) as an amber oil. 1H NMR: (400 MHz, Chloroform-d) 1H NMR: δ 1.28 (3H, t, J = 
7.1 Hz), 1.66-1.95 (5H, 1.74 (dtdd, J = 13.4, 10.2, 2.9, 2.3 Hz), 1.76 (dddd, J = 13.1, 7.9, 
2.9, 2.6 Hz), 1.77 (dddd, J = 13.1, 10.2, 3.2, 2.8 Hz), 1.82 (ddd, J = 8.1, 7.9, 2.8 Hz), 1.87 
(ddddd, J = 13.4, 3.3, 3.2, 2.6, 2.2 Hz)), 2.20 (1H, d, J = 8.1 Hz), 2.32-2.58 (2H, 2.39 
(ddd, J = 14.6, 3.3, 2.3 Hz), 2.50 (ddd, J = 14.6, 10.2, 2.2 Hz)), 4.09-4.20 (2H, 4.14 
(q, J = 7.1 Hz), 4.14 (q, J = 7.1 Hz)), 7.80 (2H, ddd, J = 8.6, 1.5, 0.5 Hz), 8.17 (2H, 






Ethyl 2-oxo-7-pentanoylbicyclo[4.1.0]heptane-7-carboxylate (2f): Purification via 
manual silica gel flash chromatography (20:1 heptanes/EtOAc to 1:1 heptanes/EtOAc) 
afforded the oxobicyclo [4.1.0] heptane-7,7-dicarboxylates product 2f (90% yield) as an 
amber oil. 1H NMR: (400 MHz, Chloroform-d) δ 0.88 (3H, t, J = 6.5 Hz), 1.21-1.37 (5H, 
1.28 (tq, J = 7.0, 6.5 Hz), 1.28 (tq, J = 7.0, 6.5 Hz), 1.31 (t, J = 7.1 Hz)), 1.47-1.61 (2H, 
1.54 (tt, J = 7.4, 7.0 Hz), 1.54 (tt, J = 7.4, 7.0 Hz)), 1.65-1.95 (5H, 1.74 (dddd, J = 13.0, 
7.9, 2.9, 2.6 Hz), 1.74 (dtdd, J = 13.4, 10.2, 2.9, 2.3 Hz), 1.78 (dddd, J = 13.0, 10.2, 3.2, 
2.8 Hz), 1.81 (ddd, J = 8.1, 7.9, 2.8 Hz), 1.87 (ddddd, J = 13.4, 3.3, 3.2, 2.6, 2.2 Hz)), 
2.19 (1H, d, J = 8.1 Hz), 2.32-2.58 (4H, 2.40 (ddd, J = 14.6, 3.3, 2.3 Hz), 2.49 (ddd, J = 
14.6, 10.2, 2.2 Hz), 2.52 (t, J = 7.4 Hz), 2.52 (t, J = 7.4 Hz)), 4.08-4.20 (2H, 4.14 (q, J = 






formaldehyde (3a): Purification via manual silica gel flash chromatography (20:1 
heptanes/EtOAc to 4:1 heptanes/EtOAc) afforded the hexahydrobenzofuranone product 
3a (80% yield) as an amber oil. 1H NMR: (400 MHz, Chloroform-d) δ 0.88 (3H, t, J = 
6.5 Hz), 1.23-1.34 (2H, 1.28 (h, J = 6.5 Hz), 1.28 (h, J = 6.5 Hz)), 1.46-1.75 (4H, 1.52 
(tt, J = 7.4, 6.5 Hz), 1.52 (tt, J = 7.4, 6.5 Hz), 1.62 (dtdd, J = 13.1, 10.2, 3.1, 2.4 Hz), 1.68 
(dddt, J = 13.1, 3.2, 3.1, 2.5 Hz)), 1.79-2.03 (2H, 1.88 (dddd, J = 14.5, 10.2, 2.8, 2.5 Hz), 
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1.96 (dddd, J = 14.5, 3.2, 2.9, 2.4 Hz)), 2.38-2.57 (4H, 2.46 (ddd, J = 14.9, 3.1, 2.5 Hz), 
2.48 (ddd, J = 14.9, 10.3, 3.1 Hz), 2.51 (t, J = 7.4 Hz), 2.51 (t, J = 7.4 Hz)), 3.49 (1H, 
d, J = 4.8 Hz), 3.76 (3H, s), 4.22 (1H, ddd, J = 4.8, 2.9, 2.8 Hz), 5.75 (1H, s), 7.17 (2H, 






formaldehyde (3b): Purification via manual silica gel flash chromatography (20:1 
heptanes/EtOAc to 4:1 heptanes/EtOAc) afforded the hexahydrobenzofuranone product 
3b (84% yield) as an amber oil. 1H NMR: δ 0.88 (3H, t, J = 6.5 Hz), 1.22-1.35 (2H, 1.28 
(tq, J = 6.6, 6.5 Hz), 1.28 (tq, J = 6.6, 6.5 Hz)), 1.46-1.75 (4H, 1.52 (tt, J = 7.4, 6.6 Hz), 1.52 
(tt, J = 7.4, 6.6 Hz), 1.62 (dtdd, J = 13.1, 10.2, 3.1, 2.4 Hz), 1.67 (dddt, J = 13.1, 3.2, 3.1, 2.5 Hz)), 
1.79-2.03 (2H, 1.88 (dddd, J = 14.5, 10.2, 2.8, 2.5 Hz), 1.95 (dddd, J = 14.5, 3.2, 2.9, 2.4 Hz)), 
2.38-2.57 (4H, 2.45 (ddd, J = 14.9, 3.1, 2.5 Hz), 2.48 (ddd, J = 14.9, 10.3, 3.1 Hz), 2.51 (t, J = 7.4 
Hz), 2.51 (t, J = 7.4 Hz)), 3.62 (1H, d, J = 4.8 Hz), 3.76 (3H, s), 4.19 (1H, ddd, J = 4.8, 2.9, 2.8 
Hz), 5.23 (1H, s), 6.18-6.33 (2H, 6.23 (dd, J = 3.4, 1.1 Hz), 6.27 (dd, J = 3.4, 1.8 Hz)), 7.40 (1H, 






one—formaldehyde (3c): Purification via manual silica gel flash chromatography (20:1 
heptanes/EtOAc to 4:1 heptanes/EtOAc) afforded the hexahydrobenzofuranone product 
3c (65% yield) as an amber oil. 1H NMR: δ 0.88 (3H, t, J = 6.5 Hz), 1.23-1.34 (2H, 1.28 
(h, J = 6.5 Hz), 1.28 (h, J = 6.5 Hz)), 1.46-1.75 (4H, 1.53 (tt, J = 7.4, 6.5 Hz), 1.53 (tt, J = 7.4, 6.5 
Hz), 1.62 (dtdd, J = 13.1, 10.2, 3.1, 2.4 Hz), 1.68 (dddt, J = 13.1, 3.2, 3.1, 2.5 Hz)), 1.79-2.04 (2H, 
1.88 (dddd, J = 14.5, 10.2, 2.8, 2.5 Hz), 1.96 (dddd, J = 14.5, 3.2, 2.9, 2.4 Hz)), 2.38-2.57 (4H, 
2.46 (ddd, J = 14.9, 3.1, 2.5 Hz), 2.48 (ddd, J = 14.9, 10.3, 3.1 Hz), 2.51 (t, J = 7.4 Hz), 2.51 
(t, J = 7.4 Hz)), 3.51 (1H, d, J = 4.8 Hz), 3.76 (3H, s), 4.11 (1H, ddd, J = 4.8, 2.9, 2.8 Hz), 5.74 
(1H, s), 7.55 (1H, ddd, J = 8.3, 7.7, 1.7 Hz), 7.67-7.87 (2H, 7.73 (td, J = 7.7, 1.7 Hz), 7.81 






formaldehyde (3d): Purification via manual silica gel flash chromatography (20:1 
heptanes/EtOAc to 4:1 heptanes/EtOAc) afforded the hexahydrobenzofuranone product 
39 
 
3d (75% yield) as an amber oil. 1H NMR: δ 0.88 (3H, t, J = 6.5 Hz), 1.23-1.34 (2H, 1.29 
(h, J = 6.5 Hz), 1.29 (h, J = 6.5 Hz)), 1.46-1.75 (4H, 1.53 (tt, J = 7.4, 6.5 Hz), 1.53 (tt, J = 
7.4, 6.5 Hz), 1.61 (dtdd, J = 13.0, 10.2, 3.1, 2.4 Hz), 1.68 (dddt, J = 13.0, 3.2, 3.1, 2.5 
Hz)), 1.76-2.08 (2H, 1.85 (dddd, J = 14.5, 10.2, 2.8, 2.5 Hz), 2.00 (dddd, J = 14.5, 3.2, 
2.9, 2.4 Hz)), 2.39-2.61 (4H, 2.47 (ddd, J = 14.9, 3.1, 2.5 Hz), 2.52 (ddd, J = 14.9, 10.3, 
3.1 Hz), 2.51 (t, J = 7.4 Hz), 2.51 (t, J = 7.4 Hz)), 3.54 (1H, d, J = 4.8 Hz), 3.76 (3H, s), 
4.15 (1H, ddd, J = 4.8, 2.9, 2.8 Hz), 5.38 (1H, s), 7.37 (1H, dddd, J = 8.0, 6.9, 1.8, 0.5 
Hz), 7.44-7.69 (3H, 7.51 (ddd, J = 9.7, 8.0, 0.5 Hz), 7.59 (ddd, J = 8.5, 6.9, 1.7 Hz), 7.62 
(ddd, J = 9.7, 1.8, 0.5 Hz)), 7.85-8.05 (3H, 7.91 (dddt, J = 8.0, 2.6, 1.8, 0.5 Hz), 7.93 





4(2H)-one—formaldehyde (3f): Purification via manual silica gel flash chromatography 
(20:1 heptanes/EtOAc to 4:1 heptanes/EtOAc) afforded the hexahydrobenzofuranone 
product 3f (75% yield) as an amber oil. 1H NMR: δ 0.88 (3H, t, J = 6.5 Hz), 1.23-1.34 (2H, 
1.28 (h, J = 6.5 Hz), 1.28 (h, J = 6.5 Hz)), 1.46-1.75 (4H, 1.53 (tt, J = 7.4, 6.5 Hz), 1.53 (tt, J = 7.4, 
6.5 Hz), 1.62 (dtdd, J = 13.1, 10.2, 3.1, 2.4 Hz), 1.68 (dddt, J = 13.1, 3.2, 3.1, 2.5 Hz)), 1.79-2.04 
(2H, 1.88 (dddd, J = 14.5, 10.2, 2.8, 2.5 Hz), 1.96 (dddd, J = 14.5, 3.2, 2.9, 2.4 Hz)), 2.38-2.57 
(4H, 2.46 (ddd, J = 14.9, 3.1, 2.5 Hz), 2.48 (ddd, J = 14.9, 10.3, 3.1 Hz), 2.50 (t, J = 7.4 Hz), 2.50 
(t, J = 7.4 Hz)), 3.50 (1H, d, J = 4.8 Hz), 3.76 (3H, s), 4.11 (1H, ddd, J = 4.8, 2.9, 2.8 Hz), 5.33 







4(2H)-one—formaldehyde (3g): Purification via manual silica gel flash chromatography 
(20:1 heptanes/EtOAc to 4:1 heptanes/EtOAc) afforded the hexahydrobenzofuranone 
product 3g (65% yield) as an amber oil. 1H NMR: δ 0.88 (3H, t, J = 6.5 Hz), 1.23-1.34 
(2H, 1.28 (h, J = 6.5 Hz), 1.28 (h, J = 6.5 Hz)), 1.46-1.75 (4H, 1.53 (tt, J = 7.4, 6.5 Hz), 
1.53 (tt, J = 7.4, 6.5 Hz), 1.62 (dtdd, J = 13.1, 10.2, 3.1, 2.4 Hz), 1.68 (dddt, J = 13.1, 3.2, 
3.1, 2.5 Hz)), 1.79-2.04 (2H, 1.88 (dddd, J = 14.5, 10.2, 2.8, 2.5 Hz), 1.96 (dddd, J = 
14.5, 3.2, 2.9, 2.4 Hz)), 2.38-2.57 (4H, 2.46 (ddd, J = 14.9, 3.1, 2.5 Hz), 2.48 (ddd, J = 
14.9, 10.3, 3.1 Hz), 2.51 (t, J = 7.4 Hz), 2.51 (t, J = 7.4 Hz)), 3.50 (1H, d, J = 4.8 Hz), 
3.76 (3H, s), 4.11 (1H, ddd, J = 4.8, 2.9, 2.8 Hz), 5.31 (1H, s), 6.95 (1H, ddd, J = 8.0, 1.7, 
1.2 Hz), 7.24-7.42 (2H, 7.30 (ddd, J = 8.0, 1.7, 1.5 Hz), 7.36 (td, J = 8.0, 0.5 Hz)), 7.58 







formaldehyde (3h): Purification via manual silica gel flash chromatography (20:1 
heptanes/EtOAc to 4:1 heptanes/EtOAc) afforded the hexahydrobenzofuranone product 
3h (71% yield) as an amber oil. 1H NMR: δ 0.88 (3H, t, J = 6.5 Hz), 1.23-1.34 (2H, 1.28 
(h, J = 6.5 Hz), 1.28 (h, J = 6.5 Hz)), 1.46-1.75 (4H, 1.53 (tt, J = 7.4, 6.5 Hz), 1.53 (tt, J = 
7.4, 6.5 Hz), 1.62 (dtdd, J = 13.1, 10.2, 3.1, 2.4 Hz), 1.68 (dddt, J = 13.1, 3.2, 3.1, 2.5 
Hz)), 1.79-2.04 (2H, 1.88 (dddd, J = 14.5, 10.2, 2.8, 2.5 Hz), 1.96 (dddd, J = 14.5, 3.2, 
2.9, 2.4 Hz)), 2.27 (3H, s), 2.38-2.57 (4H, 2.46 (ddd, J = 14.9, 3.1, 2.5 Hz), 2.48 (ddd, J = 
14.9, 10.3, 3.1 Hz), 2.51 (t, J = 7.4 Hz), 2.51 (t, J = 7.4 Hz)), 3.50 (1H, d, J = 4.8 Hz), 
3.76 (3H, s), 4.10 (1H, ddd, J = 4.8, 2.9, 2.8 Hz), 5.38 (1H, s), 7.16-7.35 (4H, 7.22 








one—formaldehyde (3i): Purification via manual silica gel flash chromatography (20:1 
heptanes/EtOAc to 4:1 heptanes/EtOAc) afforded the hexahydrobenzofuranone product 
3i (74% yield) as an amber oil. 1H NMR: δ 0.88 (3H, t, J = 6.5 Hz), 1.23-1.34 (2H, 1.28 
(h, J = 6.5 Hz), 1.28 (h, J = 6.5 Hz)), 1.46-1.75 (4H, 1.53 (tt, J = 7.4, 6.5 Hz), 1.53 (tt, J = 
7.4, 6.5 Hz), 1.62 (dtdd, J = 13.1, 10.2, 3.1, 2.4 Hz), 1.68 (dddt, J = 13.1, 3.2, 3.1, 2.5 
Hz)), 1.79-2.04 (2H, 1.88 (dddd, J = 14.5, 10.2, 2.8, 2.5 Hz), 1.96 (dddd, J = 14.5, 3.2, 
2.9, 2.4 Hz)), 2.38-2.57 (4H, 2.46 (ddd, J = 14.9, 3.1, 2.5 Hz), 2.48 (ddd, J = 14.9, 10.3, 
3.1 Hz), 2.51 (t, J = 7.4 Hz), 2.51 (t, J = 7.4 Hz)), 3.50 (1H, d, J = 4.8 Hz), 3.76 (3H, s), 
4.11 (1H, ddd, J = 4.8, 2.9, 2.8 Hz), 5.32 (1H, s), 7.07 (1H, ddd, J = 8.0, 1.5, 1.4 Hz), 
7.25 (1H, dt, J = 8.1, 1.6 Hz), 7.33-7.57 (2H, 7.40 (ddd, J = 8.1, 8.0, 0.5 Hz), 7.52 































































 Selective Synthesis of Pyrrolidines, Pyrrolines, and Azepines  
From Haloaziridines 
 
Pyrrolidines, pyrrolines, and azepines and their derivatives are critically important 
classes of heterocyclic compounds that contain one nitrogen atom. The GML lab group is 
interested in the development of novel methodologies for the synthesis of these key 
organic skeletons and, more specifically, the selective synthesis of halogenated nitrogen 
containing heterocyclic compounds from haloaziridine precursors. Pyrrolidines, also 
known by the chemical name tetrahydropyrrole, are a class of organic compounds which 
are characterized by a pentane ring containing four carbons and one nitrogen. 
Pyrrolidines have the chemical formula C4H9N and the molecular formula (CH2)4NH. 
Pyrrolines and its isomeric forms, 1-pyrroline, 2-pyrroline, and 3-pyrroline are a class of 
organic compounds distinguished by a pentane ring containing four carbon atoms and one 
nitrogen atom with the chemical formula C4H7N. Azepines are denoted by a heptane ring 
containing six carbon atoms and one nitrogen atm and have the chemical formula 
C6H11N. Figure 11 illustrates, pyrroline, azepine, and pyrrolidine respectively from left to 
right, the nitrogen containing heterocyclic target moieties previously mentioned that will 
be discussed in this chapter. The general synthesis routes and applications of each organic 
moiety, pyrroline, pyrrolidine, and azepine, will be touched upon in the following section 
but synthesizing halogenated versions of these nitrogen-containing heterocycles will be 










2.1 Synthesis of Pyrrolidines, Azepines, and Pyrrolines 
When studying various organic methods designed to synthesize a target moiety in 
mind, it is crucial to locate one of the first examples of the synthesis of the target moiety 
to receive insight into where the development of these compounds began. One of the first 
methods to synthesize pyrrolines and pyrrolidines was completed by Bucherer and Seyde 
in 1908 by reacting 3-hydroxy-2-naphthoic acid with phenyl hydrazine in the presence of 
sodium bisulfate under reflux for 18 hours. This procedure afforded pyrroline-containing, 
sodium salt of benzo-carbazole sulfonic acid as a yellow crystalline mass in 75% yield. 
(46) An initial synthetic route to bear azepine-containing moieties was for the multi-step 
synthesis of substituted tetrahydrobenzazepines by Bobowski and co-workers in 1979. 
The substituted tetrahydrobenzazepines are important organic moieties as they were 
found to exhibit arrhythmic activity in an ouabain-induced arrythmia. (47) To begin this 
synthesis route, arylaldehydes and 2-nitropropanes were run through a condensation 
reaction to generate nitro-alcohols which were then reduced to alcohol amines catalyzed 
by zinc and acetic acid. Another condensation reaction was run between the provided 
nitro-alcohols and arylacetaldehydes to give an imino complex derivative which was 
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reduced with borohydride to achieve a secondary amine complex. Finally, the secondary 
amine complex was reacted with various mineral acids to complete the final cyclization 
reaction to give the tetrahydrobenzazepines derivative. (48) 
Now that initial synthetic examples of pyrroline, pyrrolidine, and azepines have 
been given, general synthetic routes to afford these moieties will be considered along 
with, in the following section, synthetic methods that grant the ability to produce 
halogenated pyrroline, pyrrolidine, and azepine moieties. The synthesis of pyrrolines and 
pyrrolidines will be briefly discussed by reviewing current organic methods including 
catalytic and non-catalytic cyclization reactions, ring expansion reactions, ring close 
metathesis and a few other instances. (49) In the first general synthetic method of 
catalytic/non-catalytic cyclization reactions, an efficient aza-Cope-Mannich cyclization 
was presented by Ruben and coworkers in which 2-hydroyl homoallyl tosylamine and 
aldehydes were reacted in the presence of iron(III) salts to afford 3-alkyl-1-tosyl 
pyrrolines in good yields. This cyclization process involved the generation of a γ-
unsaturated iminium ion followed by a sigmatropic rearrangement and finally an 
intramolecular Mannich reaction. (50) Iron (III) salts are shown in Ruben’s work to be 
excellent catalysts for new aza-Cope-Mannich cyclization using 2-hydroxy 
homopropargyl tosylamine.  
 Liang Y and collaborators have also developed an efficient one-pot 
synthesis of substituted pyrrolines in aqueous media. This method involves the treatment 
of a range of various chalcone derivatives with aqueous sodium hydroxide in N,N-
dimethylformamide to undergo a room temperature Michael addition reaction with 
nitroalkanes. The resulting adducts were then directly reduced in situ with Zn/HCl which 
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induced intramolecular cyclization generating the corresponding substituted pyrrolines in 
high yields. (51) A non-catalytic cyclization reaction to afford the pyrroline moiety was 
completed by Ohno and colleagues in which alpha amino allenes bearing an amino 
protecting group were reacted with potassium carbonate in DMF under reflex without the 
presence of a transition-metal catalyst giving the corresponding 3-pyrrolines in excellent 
yields. This non-catalytic cyclization reaction occurred via an endo-trig 
cycloisomerization as internal allenes with axial chirality were able to form the 3-
pyrrolines in a stereoselective manner. (52)  
 Kumar and colleagues have reported the synthesis of pyrrolines through a 
ring expansion reaction using aziridines as molecular precursors. In this organic 
procedure, silver nitrate and chloramine-T were used for the transformation of alkene 
derivatives into the respective aziridines. The rendered aziridines were reacted in the ring 
expansion reaction with acrylo-nitrile and ethyl acrylate using solid sodium hydroxide as 
the base in the organic solvent tetrahydrofuran to bear 1-pyrrolines in 40-58% yields. 
(THF) (56) 
 Pyrrolidines have also been afforded through catalytic cyclization reactions 
such as in the Hofmann-Loffler-Freytag reaction. In this organic procedure, cyclic amines 
are generated through thermal or photo-chemical decomposition of N-halogenated amine 
in the presence of a strong acid such as triflic acid or sulfuric acid. This reaction occurs 
via intramolecular hydrogen atom transfer of the N-halogenated amine to a nitrogen-
centered radical which enables intramolecular free radical C-H functionalization and 
cyclization, under basic conditions, to yield pyrrolidines. (49)  
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 Another two catalytic cyclization reactions to afford pyrrolidines can be 
found in a one-pot synthesis routes depicted in Figure 12. The first one-pot pyrrolidine 
synthesis route, shown at the top of Figure 12, uses an amino alcohol to go through a 
halogenation-cyclization reaction which is induced by 3 equivalences of thionyl chloride 
in the organic solvent dimethyl ethane at room temperature for two to six hours.  (53) The 
second one-pot pyrrolidine synthesis, shown at the bottom of Figure 12, reacts 
dihaloalkanes with alkyl and aryl amines separately in the presence of 1.1 equivalences of 
potassium chloride under 70-100W of microwave irradiation at 120 degrees Celsius for 
20 minutes to produce pyrrolidines. (57) 
 
Figure 12  






 Yang, Alper, and Xiao have displayed an efficient manner for the synthesis 
of chiral pyrrolidines via a ring-closing enyne metathesis. To complete this reaction, 1 
mmol of enyne precursor was dissolved into 17 milliliters of freshly distilled and 
degassed dichloromethane under elemental nitrogen gas. Positive pressure was induced 
with nitrogen gas syringed into the reaction vial and the reaction stirred for 10 minutes in 
reflux. A ruthenium catalyst was then syringed into the reaction vial and the reaction was 
left to run for 14-20 hours in reflux to generate the respective chiral pyrrolidines. (58)  
 Metal catalyzed cyclization and cycloaddition reactions have also been 
presented to impart the production of complex pyrrolidines. Shi and co-workers have 
prepared synthesized pyrrolidines through a gold catalyzed reaction between methylene 
cyclopropanes and sulfonamide in toluene at 85 degrees Celsius. (59) In another metal 
catalyzed cyclization reaction to afford pyrrolidines occurred from Komeyama and 
colleagues through hydroamination via inactivated olefins. These olefins are activated by 
by iron (III) chloride in dichloroethane at 80 degrees Celsius for 2-38 hours producing 
pyrrolidines in an efficient manner. (60)  
 Now that a brief overview at the current methods to synthesize both 
pyrrolines and pyrrolidines have been discussed, the focus will now turn to the synthesis 
of azepines that are currently available. Azepines have been synthesized by a multitude of 
groups using organic methods such as insertion reactions, cyclo-expansion reaction, ring-
closing metathesis, and many more. (61) In the first synthetic example of azepines, 
depicted in Figure 13, shows intermolecular insertion of nitrenes across a benzene double 
bond at high temperature and pressure to produce the ring-expanded product H-
soulfonyl-1H-azepine.This thermolysis reaction of toluene-9-sulfonyl azide was 
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performed with excess benzene under high nitrogen pressure at 155 to 160 degrees 
Celsius and afforded side products in miniscule yields. (62)  
   
Figure 13  




 Another insertion rection between nitrene and benzene was generated in situ 
through reaction of phenyl nitrene and benzene. This reaction undergoes an addition 
reaction to form an intermediate which then catalyzes the insertion reaction to afford the 
N-phenyl-1H-azepines in high yields. (63) Conjugative addition of secondary formamide 
to nitroalkenes gives INOC precursors within 2-4 hours in yet another synthetic strategy 
to afford azepines. The intramolecular nitrile oxide cycloaddition, INOC, precursors are 
exposed to phenyl isocyanate under basic conditions and afford nitrile oxides which 
immediate react with internal alkenes to give bicyclic isoxazole-fused azepines in fair 
yields. (64)  
 One final example of a synthetic strategy to afford azepine moieties is 
through ring closing metathesis reactions. Fürstner and colleagues have shown that α,ω-
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diene or ene-yne systems can undergo ring closing metathesis, catalyzed by the Grubbs 
catalyst, to provide pyrrolidine-derived α,ω-dienes such as pyrrolidinoazepinone. (65) 
Now that a brief review of the current methods employed to synthesize pyrrolidine, 
pyrrolines, and azepines has been discussed, the pharmaceutical application of these 
featured organic structures will be reviewed. 
2.2 Pharmaceutical Relevance  
Pyrrolidines, pyrrolines, and azepines are a crucially important families of 
nitrogen containing heterocyclic, organic compounds which are shown to have varied 
biological activities. When pyrrolidines, pyrrolines, or azepines are further 
functionalized, or substituted, the resulting complex heterocyclic derivatives have shown 
a wide variety of different antibacterial effects and significant biological activities. 
Complex pyrrolidine moieties, for example, are used as scaffolding molecules to 
synthesize unnatural oligomers. These synthetically made polymers, also known as 
unnatural oligomers, show many diverse applications in the pharmaceutical industry as 
antidiabetic, anticancer, antimalarial, antiviral, antimicrobial, anti-inflammatory, and 
antibacterial agents. The following section will illustrate a few pharmaceutical 
applications which employ pyrrolidines, pyrrolines, and azepines.  
 One of the first pharmaceutical applications that can be considered for nitrogen-
containing heterocyclic compound can be seen through the presence of these structures 
within natural products that are used in daily life as well as in synthetic organic 
chemistry. Natural alkaloids including nicotine, hygrine, atropinone, and proline are just 
a few examples of widely used natural products that have the pyrrolidine ring 
substructure within each of the natural product’s molecular skeleton. (61) For 
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applications within synthetic organic research, the pyrrolidine substructure acts as a great 
nucleophile which can easily perform electrophilic substitution reaction with different 
electrophiles including alkyl halides and acyl halides to provide substituted pyrrolidine 
derivatives. Once these pyrrolines are formed, they can undergo even further 
transformations such as N-alkylpyrrolidines which can produce quaternary salts on 
further reaction with alkyl halides. Pyrrolidines have also been shown to react with 
ketene thioacetals to synthesize mono- and di-pyrrolidino derivatives. One final example 
of the synthetic application of pyrrolidines can be seen between the reaction of 
pyrrolidines with alkyl/aryl isocyanates or isothiocyanates deliver the respective 1,3-
disubstituted urea/thiourea products. (61) 
Gataullin and co-workers have synthesized N-tosyl-2-(1-halogeneethyl)-3-
methylindolines through halocyclization of homologues of N-tosyl2-(1-methylbut-2-en-
1-yl)aniline and 2-chloro-, 2-bromo-, and 4-bromo-derivatives. N-tosyl-2-(1-
halogeneethyl)-3-methylindolines synthesized by Gataullin and co-workers have shown 
selective toxicity against SH-SY5Y cell lines which are often used as in vitro models of 
neuronal function and differentiation. The synthesis of these N-tosyl-2-(1-halogeneethyl)-
3-methylindolines begins with the N-alkenylation of halogenated anilines which 
chloropentene in triethylamine at 80 degrees Celsius. A thermal Claisen rearrangement 
was then conducted on the hydrochloride penteneyl aniline in the presence of xylene. The 
aniline derivatives produced then undergo reaction with tosyl chloride in pyridine to 
afford cis and trans toluene sulfonyl amide derivatives which then undergo hetero-
cyclization reaction in the presence of molecular iodine and sodium bicarbonate in 
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dichloromethane at 20 degrees Celsius. The corresponding cis and trans isomers of N-
tosyl-2-(1-halogeneethyl)-3-methylindolines are then produced. (82) 
Pyrrolines have also been shown to have useful biological applications within the 
pharmaceuticals industry. Pyrroline-5-carboxylate synthase (P5CS), for example, is a 
bifunctional enzyme that exhibits glutamate kinase (GK) and gamma-glutamyl phosphate 
reductase (GPR) activities. This P5CS enzyme is highly relevant in humans as it belongs 
to a combined biochemical route for the conversion of glutamate, ornithine and proline. 
Humans that have a P5CS deficiency exhibit a rare, metabolic disease that can be life 
threatening if not addressed. It is well established that some bacteria and plants also 
accumulate prolines in response to osmotic stress. The analyzed structures of GK and 
GPR exemplify the importance of prolines in P5CS’s as they are present in a variety of 
different species. (68)  
Another biologically crucial proline derivative can be seen in D-Pyrroline-5-
carboxylic acid, an intermediate in both the biosynthesis and degradation of L-proline. D-
pyrroline-5-carboxylic acid was recently synthesized and isolated as a pure compound 
through enzymatic assay with pyrroline-5-carboxylate reductase from Escherichia coli by 
the periodate oxidation of hydroxylysine. (69) 
As chiral, pyrroline moiety-containing, tetrahydroindoles are represented in 
natural products such as strychnine and mesembrine, a synthesis of chiral 
tetrahydroindoles has been developed via a Pd-catalyzed asymmetric allylic substitution 
annulation using unstable enolizable ketimines as nucleophiles and t-BuRuPHOX as a 
chiral ligand. This reaction is depicted in Figure 14 below. The tetrahydroindole synthesis 
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proceeds via an asymmetric desymmetrization of the mesodiacetate cycloalkenes, 
generating the desired chiral tetrahydroindoles in excellent, 96% ee, yields. The 
annulation reaction could be performed on a gram-scale in high yields and the resulting 
products can be transformed to several types of N-hetereo bicyclic derivatives. (83) 
 
Figure 14 
Palladium Catalyzed Synthesis of Tetrahydroindoles 
 
 
Azepines have also shown to be malleable organic constructs that can undergo 
useful transformations to generate complex scaffolds that are likely characterized with 
biological activities. As shown in Figure 15, if the nitrogen atom of 1H-azepines contains 
an electron withdrawing group, of 2-azabicyclo [3.2.0] hepta-3,6-dienes can be produced 
under photochemical conditions. Interestingly, the reverse reaction can occur by 
producing 1H-azepines from of 2-azabicyclo [3.2.0] hepta-3,6-dienes through thermal 





Figure 15  
Functionalization of EWG Substituted 1H-Azepines 
 
 
Azepines can also undergo alkylation reactions as tricarbonyl [4-1-
(ethoxycarbonyl)-1H-azepine] iron complex alkylation occurs through a Friedel-Craft 
approach by using a 2-oxallyl cation. This cation is first generated by the reaction of 2,4-
dibromo-2,4-dimethylpentan-3-one and Fe(CO)9. (67)  
 Finally, azepines can be seen in innate natural products such as flueggenine C, 
fluevirosine D, and phyllantidine which are depicted in Figure 16. Lee and colleagues 
studied various synthetic routes that are currently available to afford these structures. In 
the first mode of diversification to produce flueggenine C, as well as fluevirosine D, a 
Rauhut-Currier reaction is undertaken each respective natural product precursor which 
involves the formation of a carbon-carbon bond. (84) The other notable mode of 
diversification that was used in the organic precursors by Lee and colleagues to afford 
these azepine natural product derivatives was through oxidation procedures. The 
oxidation of the tertiary amine moiety of securinega precursors yielded nitrogen-oxide 
derivatives which could serve as a branching point for various high-oxidation state 
securinega alkaloids. An example of the production of a high-oxidation state securinega 
alkaloid natural products from nitrogen-oxide derivatives could use the Meisenheimer 
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rearrangement on these produced nitrogen-oxide derivatives to yield the natural product 
phyllantidine, also depicted in Figure 16. (85) 
 
Figure 16  
Azepine-Containing Natural Products 
 
 
2.3 Results and Discussion 
 As depicted in the previous sections of this chapter, pyrrolidines, pyrrolines, and 
azepines are crucial nitrogen-containing, heterocyclic organic structures that show up 
extensively within valuable natural products, in the molecular skeleton of 
pharmacophores, and as intermediates for the synthesis of complex pharmacophores. 
Because of the scarcely of novel synthetic methods to afford pyrrolidines and azepines 
the GML lab group developed a reaction hypothesis, depicted in Table 7, to provide these 
nitrogen containing heterocycles from haloaziridines. Halogen bonding was an important 
aspect to the products formed by the GML lab group as it added a layer of diversification 
to the nitrogen containing heterocycles synthesized. Halogen bonding is exemplified as 
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covalent bonding formed between a halogen atom, such as bromine or iodine, and a 
nucleophile such as a Lewis base. Halogen bonding that exists within organic products 
are highly directional and specific organic interactions that emulate the reactivity of 
hydrogen bonding. (78) Due to the anisotropy of the charge distribution of halogen 
atoms, a positively charged electrostatic region on the extension of the halogen bond, 
termed the σ-hole, interacts attractively with a nucleophile to make the attached halogen 
atom a good leaving group. (79)  Over the past few years halogen bonding has more 
attention for its role in drug discovery which has led the GML lab group to include them 
in their novel synthetic methods. The haloaziridines produced in the reaction hypothesis, 
in Table 7, are formed by transformation of halogenated allylic alkene derivatives 
through reaction with chloramine T in the organic solvent acetonitrile at room 
temperature. From this point, the haloaziridine derivatives produced are to undergo 


















 Once the reaction hypothesis was formed, optimization studies for the synthesis of 
haloaziridines was started by trying to maximize the haloaziridine yields. At the 
beginning of the optimization studies, haloaziridine conversion was lacking so the GML 
lab group employed the addition of iodine sublimed as a co-additive in order to convert 
major side product of the halo-aziridination reaction, N-allyl-4-
methylbenzenesulfonamide into the aforementioned haloaziridine product. A solvent 
study was also conducted on the reaction including the use of dichloromethane, 
acetonitrile, chloroform, and benzene. As acetonitrile proved to show the best conversion 
by NMR analysis, an organic solvent concentration study was performed which resulted 
in the 0.05 M concentration of the acetonitrile. The scope of the haloaziridines produced 


















































2.3.1 Haloaziridine Cycloaddition Initial Studies 
Initial studies were conducted on the transformation of the allylic bromide 
haloaziridine derivative into the pyrrolidine, pyrroline, and azepine moieties. Boron 
trifluoride ethyl etherate, silver hexafluoroantimonate(V), and chloro (1,5-
cyclooctadiene) rhodium(I)dimer were reacted with the haloaziridine derivative in 
dichloroethane at 80 degrees Celsius to afford the pyrrolidine, pyrroline, and azepine 
moieties, respectively. The presence of these heterocyclic constructs were confirmed by 
NMR analysis in the crude products but further optimization is still required to maximize 














A diastereoselective and efficient methodology was developed for the selective 
synthesis of complex haloaziridines from allylic alkene derivatives. This overall reaction 
will allow for the direct conversion of commercially available alkenyl halides in the 
corresponding haloaziridines in the presence of chloramine T as the nitrogen source and 
iodine sublimed to convert the main predicted organic side product into haloaziridines. 
Initial studies on the conversion of these afforded haloaziridines into pyrrolidines, 
pyrrolines, and azepines has been conducted and further optimization is needed. Initial 
studies have proven that haloaziridines can be used as suitable templated for the synthesis 
of nitrogen-containing heterocycles with high product conversion and stereoselectivity. 
2.5 Experimental  
Organic reagents were obtained from Aldrich Chemical, Acros Organics, and Alfa 
Aesar. Organic reactions were performed with 20 milliliter glass vials that allowed for 
magnetic stirring. TLC analysis was performed via a 0.25mm E. Merck silica gel 60 F254 
plates and visualized under 254 nm UV light as well as staining with potassium 
permanganate solution (KMnO4). Products were purified via manual silica-gel flash 
chromatography and collected based on NMR analysis and Rf values of UV spots by 
TLC. NMR spectrum were recorded via Varian Mercury II 400 MHz Spectrometer at 24 
degrees Celsius in CDCl. Chemical shifts are expressed in ppm relative to solvent 





2.5.1 General Method for the Synthesis of Haloaziridines 
 A twenty-milliliter vial was obtained for this reaction and was filled with 0.1 M of 
the organic solvent acetonitrile. Alkenes that had functional groups in the allylic position 
were of interest for this project’s transformation. 0.4132 mmol of dry chloramine T was 
put into a separate vial and put under high vacuum pressure for thirty minutes in order to 
ensure it was completely dry. 0.2066 mmol of allyl bromide was syringed into the 
reaction vial containing the 0.1M acetonitrile as well as a magnetic stir bar. The dry 
chloramine T was then poured into the vial. The reaction was left to spin on a hotplate for 
fifteen minutes at which point 0.2066 mmol of iodine sublimed was added to the reaction 
vial. The reaction was then left to run overnight.  
The following day the workup, characterization, and analysis of the halo-aziridine 
formation took place. The aziridine reaction was taken off the hotplate, the stir bar was 
removed with a magnetic stir rod, and the stir bar was cleaned. A clean 250 milliliter 
Erlenmeyer flask was obtained along with a plastic funnel and a circular piece of filter 
paper. The filter paper was folded and placed into the funnel and the funnel was then 
placed into the 250 milliliter Erlenmeyer flask. A glass pipette was obtained with an 
attached rubber bulb and used to squirt acetonitrile on the filter paper before the gravity 
filtration of the reaction began. Gravity filtration was complete to remove the chloramine 
T. Once the crude product was confirmed by TLC and NMR, manual, silica-based, flash 
column chromatography was performed to isolate the pure haloaziridine product. The 
pure haloaziridine was characterized/confirmed via proton/carbon NMR, infrared 
spectroscopy (IR), and mass spectrometry (MS).  
71 
 




2-[bromo(phenyl)methyl]-1-(4-methylbenzene-1-sulfonyl)aziridine (2c): Purification 
via manual silica gel flash chromatography (100:1 heptanes/EtOAc to 20:1 
heptanes/EtOAc) afforded the haloaziridine product 2c as a clear oil. 1H NMR: δ 2.32 
(3H, s), 3.13 (1H, dd, J = 8.1, 4.1 Hz), 3.29-3.47 (2H, 3.36 (dd, J = 7.6, 4.1 Hz), 3.39 
(ddd, J = 8.1, 7.6, 6.5 Hz)), 4.85 (1H, d, J = 6.5 Hz), 7.23-7.53 (7H, 7.30 (tt, J = 7.7, 1.5 
Hz), 7.33 (dddd, J = 7.9, 1.5, 1.3, 0.5 Hz), 7.34 (ddd, J = 7.9, 1.8, 0.4 Hz), 7.46 







Purification via manual silica gel flash chromatography (100:1 heptanes/EtOAc to 20:1 
heptanes/EtOAc) afforded the haloaziridine product 2e as a clear oil. 1H NMR: δ 1.19 
(3H, s), 1.46-1.59 (8H, 1.52 (t, J = 7.4 Hz), 1.52 (t, J = 7.4 Hz), 1.54 (s), 1.54 (s)), 1.97-
2.10 (2H, 2.04 (td, J = 7.4, 7.1 Hz), 2.04 (td, J = 7.4, 7.1 Hz)), 2.32 (3H, s), 3.07-3.23 
(2H, 3.13 (dd, J = 8.1, 4.1 Hz), 3.16 (dd, J = 8.1, 7.6 Hz)), 3.39 (1H, dd, J = 7.6, 4.1 Hz), 






2-(Iodomethyl)-1-(4-methylbenzene-1-sulfonyl)aziridine (2g): Purification via manual 
silica gel flash chromatography (100:1 heptanes/EtOAc to 20:1 heptanes/EtOAc) 
afforded the haloaziridine product 2g as a clear oil. 1H NMR: δ 2.32 (3H, s), 3.13 (1H, 
dd, J = 8.1, 4.1 Hz), 3.30-3.59 (4H, 3.37 (dd, J = 7.6, 4.1 Hz), 3.48 (d, J = 3.2 Hz), 3.48 
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(d, J = 3.2 Hz), 3.52 (ddt, J = 8.1, 7.6, 3.2 Hz)), 7.32 (2H, ddd, J = 7.9, 1.8, 0.4 Hz), 7.70 




2-(bromomethyl)-1-(4-methylbenzene-1-sulfonyl)aziridine (2a): Purification via 
manual silica gel flash chromatography (100:1 heptanes/EtOAc to 20:1 heptanes/EtOAc) 
afforded the haloaziridine product 2a as a clear oil. 1H NMR: δ 2.32 (3H, s), 3.13 (1H, 
dd, J = 8.1, 4.1 Hz), 3.33 (1H, dd, J = 7.6, 4.1 Hz), 3.49 (1H, ddt, J = 8.1, 7.6, 3.2 Hz), 
3.98-4.09 (2H, 4.04 (d, J = 3.2 Hz), 4.04 (d, J = 3.2 Hz)), 7.34 (2H, ddd, J = 7.9, 1.8, 0.4 





2-(1-bromoethyl)-1-(4-methylbenzene-1-sulfonyl)aziridine (2f): Purification via 
manual silica gel flash chromatography (100:1 heptanes/EtOAc to 20:1 heptanes/EtOAc) 
afforded the haloaziridine product 2f as a clear oil. 1H NMR: δ 1.45 (3H, d, J = 6.7 Hz), 
2.32 (3H, s), 3.07-3.40 (3H, 3.13 (dd, J = 8.1, 4.1 Hz), 3.23 (ddd, J = 8.1, 7.6, 4.3 Hz), 
3.34 (dd, J = 7.6, 4.1 Hz)), 4.21 (1H, qd, J = 6.7, 4.3 Hz), 7.32 (2H, ddd, J = 7.9, 1.8, 0.4 





2-(chloromethyl)-1-(4-methylbenzene-1-sulfonyl)aziridine (2h): Purification via 
manual silica gel flash chromatography (100:1 heptanes/EtOAc to 20:1 heptanes/EtOAc) 
afforded the haloaziridine product 2h as a clear oil. 1H NMR: δ 1.36 (3H, d, J = 5.4 Hz), 
2.32 (3H, s), 3.37-3.53 (2H, 3.44 (dq, J = 8.1, 5.4 Hz), 3.47 (dt, J = 8.1, 3.3 Hz)), 4.11-
4.22 (2H, 4.16 (d, J = 3.3 Hz), 4.16 (d, J = 3.3 Hz)), 7.32 (2H, ddd, J = 7.9, 1.8, 0.4 Hz), 







2-(1,2-dibromoethyl)-1-(4-methylbenzene-1-sulfonyl)aziridine (2d): Purification via 
manual silica gel flash chromatography (100:1 heptanes/EtOAc to 20:1 heptanes/EtOAc) 
afforded the haloaziridine product 2d as a clear oil. 1H NMR: δ 2.32 (3H, s), 3.09-3.46 
(3H, 3.16 (dd, J = 8.1, 4.1 Hz), 3.28 (ddd, J = 8.1, 7.6, 3.2 Hz), 3.39 (dd, J = 7.6, 4.1 
Hz)), 3.50-3.61 (2H, 3.56 (d, J = 5.4 Hz), 3.56 (d, J = 5.4 Hz)), 4.32 (1H, td, J = 5.4, 3.2 
Hz), 7.32 (2H, ddd, J = 7.9, 1.8, 0.4 Hz), 7.70 (2H, ddd, J = 7.9, 1.5, 0.4 Hz). 
 






















 Photo-Induced Isomerization of Vinyl Nitrones to Vinyl Oxaziridines 
 
Oxaziridines are classically valuable moieties that become the targets for many 
organic chemists looking to improve on the organic methodologies involved with making 
complex pharmacophores as well as natural products. Research involving oxaziridines 
over the past five decades has been motivated by the unusual physical properties 
possessed by these compounds as well as their distinctive reactivity. Oxaziridines can be 
characterized in Figure 17 by a three membered organic ring containing one carbon atom, 
one nitrogen, and one oxygen atom. The presence of these two electronegative atoms 
allow for further functionalization of oxaziridines into more complex heterocycles as, 
under varying reaction conditions, the carbon-nitrogen bond, carbon-oxygen bond, and 
oxygen-nitrogen bond can all be cleaved in order to afford a slew of heterocycles with an 
added level of functionalization. The following section will introduce oxaziridines by 







3.1 Synthesis of Oxaziridines 
Oxaziridines have shown to be crucial organic scaffolds as well as acting as 
reagents for the synthesis of even more complex heterocyclic containing complexes. One 
of the most well characterized reactivities that oxaziridines can provide to organic 
chemists is their ability to serve as electrophilic oxygen transfer reagents. Numerous, 
thorough reviews have been published with a focus on oxaziridines used as electrophilic 
oxygen transfer reagents. (70) There has been recent significant growth of synthetic 
routes that have become available in oxaziridine chemistry allowing for the synthesis of 
highly functionalized, stereospecific oxaziridine moieties. The following brief review, in 
this section, of the current methods to provide oxaziridines will be organized via the 
substituent of the nitrogen atom in the oxaziridine moiety.  
The first class of N-substituted oxaziridines explored by organic chemists were N-
alkyl-substituted oxaziridines, initially synthesized by Emmons and coworkers in 1957. 
The standard method for Emmon’s preparation of the N-alkyl-substituted oxaziridines 
involves the oxidation of an imine to then afford the corresponding oxaziridine. The use 
of peroxy-acids, described in Emmons initial report and depicted in Figure 18, such as m-
chloroperbenzoic acid (mCPBA) to oxidize imines continues to be the most common 
method utilized by organic chemists today for oxaziridine synthesis. Experimental and 
theoretical studies of Emmon’s oxaziridines synthesis support a two-step mechanism for 





Figure 18  
Emmons Synthesis of N-Alkyl Substituted Oxaziridines 
 
 
The next class of oxaziridines which will be discussed are N-unsubstituted 
oxaziridines. N-Unsubstituted oxaziridines are useful organic moieties as they are highly 
reactive toward nucleophiles and are usually formed in situ in inert solvents and reacted 
further without the need for additional purification procedures.  (70) Oxaziridines bearing 
unsubstituted nitrogen atoms are generally not synthesized by standard peracid oxidation 
methods due to the instability of N-H imines. Schmitz et al. have reported the preparation 
of N- unsubstituted oxaziridines through the reaction of cyclohexanone with ammonia 
and sodium hypochlorite. (72) 
Another notable type of N-substituted oxaziridines, to which previously 
developed methods exist, are N-sulfonyloxaziridines. N-sulfonyloxaziridines are highly 
selective, neutral, aprotic oxidizing reagents that have found, and are continuing to find, 
increased utility in organic synthesis. Enantiomerically pure examples of N-
sulfonyloxaziridines are useful asymmetric oxidizing reagents to afford high 
stereoselectivities for the asymmetric oxidation of sulfides (selenides) to sulfoxides 
(selenoxides) (66 to >95% ee), for the epoxidation of alkenes (up to 65% ee), and for the 
asymmetric oxidation of enolates to optically active hydroxycarbonyl compounds (55-
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95% ee). (73) The earliest attempts to prepare optically active N-sulfonyloxaziridines 
relied on catalysis from chiral camphor-based peracids. (74)  This was not viable for 
continued use as the approach suffers from low selectivity and repeated fractional 
recrystallizations are required to achieve high optical purity using this protocol. The first 
synthetically useful approach to chiral N-sulfonyloxaziridines was based on the synthesis 
of camphor sulfonic acid derived imines which can be selectively oxidized with oxone to 
give the corresponding chiral N-sulfonyloxaziridines. This oxidation can only take place 
from the endo face of the carbon and nitrogen double bond due to the steric blocking of 
the exo-face, resulting in a single oxaziridine isomer (75) Because of the multitude of 
uses discovered with N-sulfonyloxaziridines chemistry, N-sulfonyloxaziridines have 
quickly become the most extensively utilized class of oxaziridines in organic synthesis 
research due of their stability, ease of synthesis, and superior oxidizing ability compared 
to N-alkyloxaziridines. Now commonly referred to as “Davis’ oxaziridines”, N-
sulfonyloxaziridines are prepared through oxidation of the corresponding N-sulfonyl 
imines, which in turn can be prepared by condensation of sulfonamides (R-SO2NH2) with 
aromatic aldehydes using either Bronsted or Lewis acids. (70) 
The final N-substituted oxaziridines that will be discussed in this chapter are N-
phosphinoyl substituted oxaziridines. Oxaziridines bearing the N-phosphinoyl 
substitution groups were first synthesized by Boyd et al. (76) This featured class of 
substituted oxaziridines are typically accessed via a reaction of an aryl oximes with 
chlorodiphenylphosphine, followed by oxidation of the corresponding, rearranged N-
phosphinoyl imines with mCPBA. The oxaziridines produced from this method are 
characterized as stable compounds that have a low barrier to nitrogen inversion (∼13 
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kcal/mol) and exist in the trans-configuration. This barrier of inversion is lower than for 
the related N-sulfonyloxaziridines due to the effect of a stronger conjugative interaction 
between nitrogen and phosphorus atoms in N-phosphinoyl oxaziridines than the 
interaction between nitrogen and sulfur atoms in N-sulfonyloxaziridines in the transition 
state for epimerization. (77) Now that current methods for the synthesis of oxaziridines 
have been discussed, pharmaceutical and synthetic applications of oxaziridines will be 
reviewed. 
3.2 Pharmaceutical Relevance 
Oxaziridines have been proven time and time again to be useful reagents in both 
organic synthesis as well as in the production of molecularly complex pharmacophores. 
In each case, the stereochemistry and conformation of the afforded oxaziridines used, and 
its substituents, are critical to exploring what types of further transformations they can 
then undergo. N-Alkyl oxaziridines are useful intermediates, for example, for the 
synthesis of amides and lactams and have been used more recently to prepare chiral 
pyrrolidines and aziridines via nitrogen-centered radicals. The potential of oxaziridines as 
enzyme inhibitors has also been recognized from the findings of the previously 








Figure 19  




Another example of the application of oxaziridines, depicted in Figure 19, is 
through the synthesis of fused bicyclic lactams as non-peptide scaffolds mimicking 
peptidyl alpha-turn topology. The final product of this synthesis, the 1-azabicyclo [5.2.0] 
nonan-2-one bicyclic skeleton, has very few existing synthesis methods but the available  
routes are not straightforward and usually result in low product yields. The synthesis of  
1-azabicyclo [5.2.0] nonan-2-one lactam, containing a bridgehead nitrogen atom, is 
offered in Figure 19 by the photolysis of a cyclic oxaziridine derivative or the 
corresponding nitrone shown on the right of Figure 19. The photolysis of the cyclic 
nitrone leads to an oxaziridine intermediate before completing the transformation in the 






Figure 20  




Figure 20 illustrates another application of oxaziridines through the synthesis of 
novel bicyclic isoxazolidine-containing compounds through 1,3-dipolar cycloaddition 
reactions between cyclic allylic alcohols and oxaziridines as substrates. The power of this 
synthetic route is that the current methods for the synthesis of isoxazolidines, through the 
carbonyl imine intermediates, are currently limited to monosubstituted olefin substrates. 
This reaction shows high product conversion and the reaction substrates tolerate various 
functional groups including the cyclopropyl and amine substituents. Mechanistic studies 
suggest the stereochemistry and diasteroeselectivity of the produced isoxazolidines are 
due to the allylic cation and a carbonyl imine intermediate. (87) 
The final example of the application of oxaziridines, discussed in this section, is a 
collection of cycloaddition reactions involving the cleavage of the N−O bond of an 
oxaziridine as this type of reaction mechanism has received increased attention in the past 
few years. The value of this synthetic route comes from the fact that direct, uncatalyzed 
oxyamination reactions between oxaziridines and olefinic substrates are quite hard to 
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achieve. Desmarteau and colleagues however have reported that electron-deficient 1,1-
difluoroalkenes reacted with perfluoro-oxaziridine affords 1,3-oxazolidine in excellent 
yields. One caveat to Desmarteau’s reaction is that only electron deficient alkenes 
undergo this atypical amino-hydroxylation transformation. (88) While only a few of the 
many examples of the applications of oxaziridines have been discussed in this section, it 
is clear to see why the GML lab group have chosen these valuable moieties as target 
structures for selective synthesis within mild conditions. 
3.3 Results and Discussion 
As mentioned before, oxaziridines continue to become an ever-present molecular 
target for synthetic chemists as they are common intermediates for the synthesis of 
biologically active, complex scaffolds used in the creation of new pharmacophores. The 
work I completed in the GML lab group finished the reaction scope of the novel synthetic 
pathway for the photocatalytic synthesis of vinyl oxaziridines from vinyl nitrones. Vinyl 
oxaziridines are seen as more valuable targets than oxaziridines alone as they add two 
points of diversification to the oxaziridines structure allowing for even greater 
opportunities for further functionalization of the molecule. This pathway was initially 
achieved by first looking at the methods previously developed to synthesize the 
oxaziridine moiety. As seen in a few synthetic examples discussed in previous sections, 
imine oxidation is a preferred pathway to afford oxaziridines as imines provide superior 
heteroatom transfer agents in oxaziridine synthesis. The GML lab group had previously 
synthesized a  library of vinyl nitrones which were now available for photoisomerization 
to form their respective vinyl oxaziridines. Photoisomerization of vinyl nitrones to vinyl 
oxaziridines was an attractive organic method to explore as it provides mild reaction 
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conditions to afford the valuable oxaziridine moiety. This photocatalytic reaction 
pathway was first realized by leaving the vinyl nitrones in solution on a windowsill for 18 
hours, in the visible light from the sun, showing the lowest conversion. This method was 
then further developed to use LED light bulbs as the visible light source instead of 
sunlight as sunlight is not nearly as direct as white LED light bulbs and the vinyl nitrones 
in solution were not being excited to a state where isomerization occurs. T-
cinnamaldehydes derived nitrones were used along with white LED light in a lightbox, 
with and without catalyst, during the optimization studies which produced oxaziridines in 
excellent yields. (81) The optimization studies for this reaction can be seen in Table 12. 
The reaction hypothesis for this photoisomerization transformation can be seen in Table 
11. These results were surprising as previous reports of nitrone isomerization required 
UV irradiation in order to promote a similar transformation. (89) The reaction scopes for 
the photoisomerization transformation can be seen in Table 14 and Table 15. 
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Organic reagents were obtained from Aldrich Chemical, Acros Organics, and Alfa 
Aesar. Organic reactions were performed with 20 milliliter glass vials that allowed for 
magnetic stirring. TLC analysis was performed via a 0.25mm E. Merck silica gel 60 F254 
plates and visualized under 254 nm UV light as well as staining with potassium 
permanganate solution (KMnO4). Products were purified via manual silica-gel flash 
chromatography and collected based on NMR analysis and Rf values of UV spots by 
TLC. NMR spectrum were recorded via Varian Mercury II 400 MHz Spectrometer at 24 
degrees Celsius in CDCl. Chemical shifts are expressed in ppm relative to solvent 
signals: CDCl, (1 H, 7.23 ppm; 13C, 77.0ppm; coupling constants expressed in Hz) 
3.4.1 General Method for Synthesis of Vinyl Nitrones 
A reaction vial was obtained and 0.1M of the organic solvent acetonitrile (ACN) 
was pipetted into the vial. Next, 1.296 mmol of magnesium sulfate was weighed out and 
placed into the 20-milliliter reaction vial. 1.944 mmol of N-benzyl hydroxylamine was 
measured and added to the reaction vial followed by the final reagent which was 1.296 
mmol of a vinyl ketone or vinyl aldehyde. The reaction was run overnight at room 
temperature.  
 The workup of the crude product was started the following day. The workup of 
the vinyl nitrone created from the first step involved gravity filtration to remove the 
excess magnesium sulfate in the reaction which was then run in the rotatory evaporator to 
remove the acetonitrile in the reaction. 10 milliliters of DI water were added to the 
reaction vial and liquid/liquid extraction was performed with the water and three washes 
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of ethyl acetate. The ethyl acetate layer was collected, and sodium sulfate was added to 
remove any of the remaining water with the reaction. The reaction was then gravity 
filtered to remove the magnesium sulfate previously added. The reaction was rotatory 
evaporated and the crude product was confirmed by TLC and NMR. It was at this point 
that if the crude was an oil, manual, silica-based, flash column chromatography was 
performed to isolate the pure vinyl nitrone product. If the crude product at the end of the 
work up was a solid, then a pentane decanting was performed in order to isolate the vinyl 
nitrone shown on the left of Figure 6. The pure vinyl nitrone was characterized/confirmed 
via proton/carbon NMR, infrared spectroscopy (IR), and mass spectrometry (MS). 
3.4.2 General Method for Synthesis of Vinyl Oxaziridines 
The final step of the synthesis of vinyl oxaziridines involved taking a new 20-
milliliter reaction vial and filling it with 0.1M of the organic solvent acetonitrile. The 
pure vinyl nitrone product was weight or measured out in a syringe and added to the 20-
milliliter reaction vial. 0.005M of the [Ru(bpy)3]2+ photocatalyst was added to the 
reaction vial. One equivalence of molecular sieves was also added to the reaction vial to 
keep the creation dry. The reaction vial was then placed into a lightbox with the lightbox 
fan turned on for a total of 24 hours.  The following day, the reaction was worked up 
through gravity filtration to remove the molecular sieves followed by rotatory 
evaporation of the crude reaction solution to remove organic solvent. The crude vinyl 
oxaziridine reaction was purified via flash chromatography.  The pure vinyl oxaziridine 
was characterized/confirmed via proton/carbon NMR, infrared spectroscopy (IR), and 
mass spectrometry (MS). The reaction schematic of the final step of the synthesis of vinyl 
oxaziridine is shown below in Figure 6. 
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